<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood - Gunaratne, AW - 2015 | Cochrane Library</title> <meta content="Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood - Gunaratne, AW - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010085.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood - Gunaratne, AW - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010085.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010085.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood" name="citation_title"/> <meta content="Anoja W Gunaratne" name="citation_author"/> <meta content="Maria Makrides" name="citation_author"/> <meta content="Carmel T Collins" name="citation_author"/> <meta content="carmel.collins@health.sa.gov.au" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD010085.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/07/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010085.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010085.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010085.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Supplements; Age Factors; Fatty Acids, Omega‐3 [*administration &amp; dosage]; Food Hypersensitivity [prevention &amp; control]; Hypersensitivity [*prevention &amp; control]; Immunoglobulin E [immunology]; Postnatal Care; Prenatal Care; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010085.pub2&amp;doi=10.1002/14651858.CD010085.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="tlnpj831";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010085\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010085\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ja","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010085.pub2",title:"Maternal prenatal and/or postnatal n\\u20103 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood",firstPublishedDate:"Jul 22, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010085.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010085.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010085.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010085.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010085.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010085.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010085.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010085.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010085.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010085.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6072 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010085.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0107"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0065"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-sec-0101"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/appendices#CD010085-sec-0112"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/table_n/CD010085StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/table_n/CD010085StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#CD010085-cr-0002">Anoja W Gunaratne</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#CD010085-cr-0003">Maria Makrides</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information#CD010085-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Carmel T Collins</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information/en#CD010085-sec-0121">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 July 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010085.pub2">https://doi.org/10.1002/14651858.CD010085.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010085-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010085-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010085-abs-0002">日本語</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010085-abs-0001" lang="en"> <section id="CD010085-sec-0001"> <h3 class="title" id="CD010085-sec-0001">Background</h3> <p>Allergies have become more prevalent globally over the last 20 years. Dietary consumption of n‐3 (or omega 3) long chain polyunsaturated fatty acids (LCPUFA) has declined over the same period of time. This, together with the known role of n‐3 LCPUFA in inhibiting inflammation, has resulted in speculation that n‐3 LCPUFA may prevent allergy development. Dietary n‐3 fatty acids supplements may change the developing immune system of the newborn before allergic responses are established, particularly for those with a genetic predisposition to the production of the immunoglobulin E (IgE) antibody. Individuals with IgE‐mediated allergies have both the signs and symptoms of the allergic disease and a positive skin prick test (SPT) to the allergen. </p> </section> <section id="CD010085-sec-0002"> <h3 class="title" id="CD010085-sec-0002">Objectives</h3> <p>To assess the effect of n‐3 LCPUFA supplementation in pregnant and/or breastfeeding women on allergy outcomes (food allergy, atopic dermatitis (eczema), allergic rhinitis (hay fever) and asthma/wheeze) in their children. </p> </section> <section id="CD010085-sec-0003"> <h3 class="title" id="CD010085-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (6 August 2014), PubMed (1966 to 01 August 2014), CINAHL via EBSCOhost (1984 to 01 August 2014), Scopus (1995 to 01 August 2014), Web of Knowledge (1864 to 01 August 2014) and <a href="http://clinicaltrials.gov/ct2/home" target="_blank">ClinicalTrials.gov</a> (01 August 2014) and reference lists of retrieved studies. </p> </section> <section id="CD010085-sec-0004"> <h3 class="title" id="CD010085-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) evaluating the effect of n‐3 LCPUFA supplementation of pregnant and/or lactating women (compared with placebo or no treatment) on allergy outcomes of the infants or children. Trials using a cross‐over design and trials examining biochemical outcomes only were not eligible for inclusion. </p> </section> <section id="CD010085-sec-0005"> <h3 class="title" id="CD010085-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed eligibility and trial quality and performed data extraction. Where the review authors were also investigators on trials selected, an independent reviewer assessed trial quality and performed data extraction. </p> </section> <section id="CD010085-sec-0006"> <h3 class="title" id="CD010085-sec-0006">Main results</h3> <p>Eight trials involving 3366 women and their 3175 children were included in the review. In these trials, women were supplemented with n‐3 LCPUFA during pregnancy (five trials), lactation (two trials) or both pregnancy and lactation (one trial). All trials randomly allocated women to either a n‐3 LCPUFA supplement or a control group. The risk of bias varied across the eight included trials in this review with only two trials with a low risk of selection, performance and attrition bias. </p> <p>N‐3 LCPUFA supplementation showed a clear reduction in the primary outcome of any allergy (medically diagnosed IgE mediated) in children aged 12 to 36 months (risk ratio (RR) 0.66, 95% confidence interval (CI) 0.44 to 0.98; two RCTs; 823 children), but not beyond 36 months (RR 0.86, 95% CI 0.61 to 1.20; one RCT, 706 children). For any allergy (medically diagnosed IgE mediated and/or parental report), no clear differences were seen in children either at 12 to 36 months (RR 0.89, 95% CI 0.71 to 1.11; two RCTs, 823 children) or beyond 36 months of age (RR 0.96, 95% CI 0.84 to 1.09; three RCTs, 1765 children). </p> <p>For the secondary outcomes of specific allergies there were no clear differences for food allergies at 12 to 36 months and beyond 36 months, but a clear reduction was seen for children in their first 12 months with n‐3 LCPUFA (both for medically diagnosed IgE mediated and medically diagnosed IgE mediated and/or parental report). There was a clear reduction in medically diagnosed IgE‐mediated eczema with n‐3 LCPUFA for children 12 to 36 months of age, but not at any other time point for both medically diagnosed IgE mediated and medically diagnosed IgE mediated and/or parental report. No clear differences for allergic rhinitis or asthma/wheeze were seen at any time point for both medically diagnosed IgE mediated, and medically diagnosed IgE mediated and/or parental report. </p> <p>There was a clear reduction in children's sensitisation to egg and sensitisation to any allergen between 12 to 36 months of age when mothers were supplemented with n‐3 LCPUFA. </p> <p>In terms of safety for the mother and child, n‐3 LCPUFA supplementation during pregnancy did not show increased risk of postpartum haemorrhage or early childhood infections. </p> </section> <section id="CD010085-sec-0007"> <h3 class="title" id="CD010085-sec-0007">Authors' conclusions</h3> <p>Overall, there is limited evidence to support maternal n‐3 LCPUFA supplementation during pregnancy and/or lactation for reducing allergic disease in children. Few differences in childhood allergic disease were seen between women who were supplemented with n‐3 LCPUFA and those who were not. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010085-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010085-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010085-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010085-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010085-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010085-abs-0006">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010085-abs-0004" lang="en"> <h3>Fish oil (n‐3 or omega‐3) for pregnant mothers or breastfeeding mothers to prevent allergies in their young children </h3> <p>Fish and fish oil are the major sources of omega‐3 long chain fatty acids. Dietary marine omega‐3 fatty acid supplements during pregnancy may change the immune system of the newborn before allergic responses are established, particularly for those with a genetic predisposition to the production of the immunoglobulin E (IgE) antibody. Individuals with IgE‐mediated allergies have both the signs and symptoms of the allergic disease and a positive skin prick test (SPT) to the allergen. </p> <p>Allergy is an important public health problem that places a burden on individuals, society and healthcare costs. Allergic diseases include food allergies, eczema (atopic dermatitis), asthma or wheeze and hay fever (allergic rhinitis). Many childhood allergies continue into adulthood. </p> <p>Pregnant women, especially those from Western countries, are not eating as much fish and allergic diseases have been increasing over the time that pregnant women have been eating less fish. The unborn baby gets nutrition from his or her mother and so the mother's diet is important. Supplementing women with omega‐3 fatty acids from marine origin may be important in preventing their children from developing allergies. </p> <p>In this review of randomised controlled studies, we evaluated the effects of adding marine omega‐3 fatty acids to women’s diets during pregnancy or lactation on allergic diseases in their children. We analysed eight trials that involved 3366 women and 3175 children. The women were randomly assigned to receive a marine omega‐3 supplement (as fish oil capsules, or added to foods) or no treatment during pregnancy (five trials), during breast feeding (two trials) or both pregnancy and breast feeding (one trial). Overall, the methodological quality of the trials varied, with only two trials being at low risk of bias. </p> <p>Overall, the results showed little effect of maternal marine omega‐3 supplementation during pregnancy and/or breast feeding for the reduction of allergic disease in the children. However there were reductions in some outcomes such as food allergy during the baby's first year and eczema with marine omega‐3 supplementation in women with a baby at high risk of allergy. Currently, there is not enough evidence to say that omega‐3 supplements from marine origin during pregnancy and/or breast feeding for mothers will reduce allergies in their children. </p> <p>In terms of safety for the mother and child, omega‐3 fatty acids supplementation from marine origin during pregnancy did not show increased risk of excessive bleeding after the baby was born (postpartum haemorrhage) or early childhood infections. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010085-sec-0107" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-sec-0107">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-sec-0150">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010085-sec-0107"></div> <h3 class="title" id="CD010085-sec-0108">Implications for practice</h3> <section id="CD010085-sec-0108"> <p>Overall, there is limited evidence to support maternal n‐3 LCPUFA supplementation during pregnancy and/or lactation for the reduction of allergic disease in the children with few differences seen in allergic disease in children between women who were supplemented with n‐3 LCPUFA and those who were not. However, at some time points there were reductions in some outcomes such as IgE‐mediated food allergy, IgE‐mediated eczema and IgE‐mediated any allergy, with n‐3 LCPUFA supplementation in women with a fetus at high risk of allergy; therefore, further research is warranted. </p> </section> <h3 class="title" id="CD010085-sec-0109">Implications for research</h3> <section id="CD010085-sec-0109"> <p>As the studies included in this review used differing doses, docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) ratios and duration of n‐3 LCPUFA supplementation, and did not take into account the baseline n‐3 long chain polyunsaturated fatty acid (LCPUFA) status of the women, further research is needed to investigate the influence of these factors on childhood allergic outcomes. Trials should clearly differentiate between children at high risk of allergy and children at low risk of allergy given the suggestion of benefit to children who were at high risk of allergy. Trials should report both IgE‐mediated allergy and allergy +/‐ IgE mediation and should include follow‐up into the school years. Studies should also be conducted in other than high‐income countries to determine the generalisability of findings. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010085-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-sec-0022">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-sec-0130">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010085-sec-0022"></div> <section id="CD010085-sec-0023"> <h3 class="title" id="CD010085-sec-0023">Description of the condition</h3> <p>Over the past 20 years the prevalence of allergies in industrialised countries has increased fivefold, from approximately 4% to an estimated 20% (<a href="./references#CD010085-bbs2-0031" title="AsherMI , MontefortS , BjörksténB , LaiCKW , StrachanDP , WeilandSK , et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino‐conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi country cross‐sectional surveys. Lancet2006;368(9537):733‐43. ">Asher 2006</a>; <a href="./references#CD010085-bbs2-0071" title="PawankerRCG , HolgateST , LockeyRF , editors. WAO White Book On Allergy. World Allergy Organization (WAO), 2011. ">Pawanker 2011</a>). Allergic diseases include food allergies, atopic dermatitis (eczema), asthma and allergic rhinitis (hay fever) (<a href="./references#CD010085-bbs2-0029" title="ArkwrightPD , DavidTJ . Allergic disorders. In: McIntoshN , HelmsPJ , SmythRL , LoganS editor(s). Forfar and Arneil's Test Book of Paediatrics. 7th Edition. Churchill Livingstone, 2008:1519‐39. ">Arkwright 2008</a>). The pattern of allergy expression differs with age (<a href="./references#CD010085-bbs2-0085" title="SpergelJM , PallerAS . Atopic dermatitis and the atopic march. Journal of Allergy and Clinical Immunology2003;112(6 Suppl):S118‐27. ">Spergel 2003</a>). Food allergies and eczema are common in children under three years of age, while asthma and allergic rhinitis are more common between the ages of three and 15 years (<a href="./references#CD010085-bbs2-0078" title="SaarinenUM , KajosaariM . Breastfeeding as prophylaxis against atopic disease: prospective follow‐up study until 17 years old. Lancet1995;346(8982):1065‐9. ">Saarinen 1995</a>). Regardless of these changing patterns of allergic disease in childhood, many childhood allergies persist, with 50% of childhood asthma sufferers and 80% of allergic rhinitis sufferers continuing to experience allergic symptoms into adulthood (<a href="./references#CD010085-bbs2-0031" title="AsherMI , MontefortS , BjörksténB , LaiCKW , StrachanDP , WeilandSK , et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino‐conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi country cross‐sectional surveys. Lancet2006;368(9537):733‐43. ">Asher 2006</a>; <a href="./references#CD010085-bbs2-0032" title="BarbeeRA , MurphyS . The natural history of asthma. Journal of Allergy and Clinical Immunology1998;102(4 Pt 2):S65‐S72. ">Barbee 1998</a>; <a href="./references#CD010085-bbs2-0046" title="GreisnerWA , SettipaneRJ , SettipaneGA . Natural history of hay fever: a 23‐year follow‐up of college students. Allergy and Asthma Proceedings1998;19(5):271‐5. ">Greisner 1998</a>; <a href="./references#CD010085-bbs2-0086" title="SpergelJM . From atopic dermatitis to asthma: the atopic march. Annals of Allergy Asthma and Immunology2010;105(2):99‐106. ">Spergel 2010</a>). </p> <p>Atopy is defined as a genetic predisposition to the production of specific immunoglobulin E (IgE) antibodies to allergens and atopic people are more liable to have immune reactions that lead to allergies (<a href="./references#CD010085-bbs2-0080" title="SearsMR , HoldawayMD , FlanneryEM , HerbisonGP , SilvaPA . Parental and neonatal risk factors for atopy, airway hyper‐responsiveness, and asthma. Archives of Disease in Childhood1996;75(5):392‐8. ">Sears 1996</a>). One of the principal methods of determining specific IgE sensitisation to an allergen is the skin prick test (SPT). To perform a SPT, a drop of allergen extract is placed on the skin and a small prick is made through the drop. This allows a small amount of allergen to enter the skin. If allergic to the tested allergen, a small lump (wheal) will appear at the site of testing within 15 to 20 minutes. A test is positive if there is a mean wheal diameter of 3 mm or greater (<a href="./references#CD010085-bbs2-0033" title="Bousquet , J.Heinzerling , L.Bachert , C.Papadopoulos , N.G.Bousquet , P.J.Burney , P.G , et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy2012;67(1):18‐24. ">Bousquet 2012</a>). A positive SPT to an allergen, along with clinical allergy symptoms, forms the basis for IgE‐mediated allergy diagnosis (<a href="./references#CD010085-bbs2-0052" title="JohanssonSGO , O’B HourihaneJ , BousquetJ , Bruijnzeel‐KoomenC , DreborgS , HaahtelaT , et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy2001;56:813‐24. ">Johansson 2001</a>; <a href="./references#CD010085-bbs2-0053" title="JohanssonSGO , BieberT , DahlR , FriedmannPS , LanierBQ , LockeyRF , et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology2004;113(5):832‐36. ">Johansson 2004</a>). </p> <p>The risk of allergy is 30% greater if one first degree relative (parent or sibling) is atopic, but if both parents are atopic then the allergy risk increases to 70% (<a href="./references#CD010085-bbs2-0080" title="SearsMR , HoldawayMD , FlanneryEM , HerbisonGP , SilvaPA . Parental and neonatal risk factors for atopy, airway hyper‐responsiveness, and asthma. Archives of Disease in Childhood1996;75(5):392‐8. ">Sears 1996</a>). Allergic responses are reactions to an extrinsic substance (allergen) that is mediated by an immunological response (<a href="./references#CD010085-bbs2-0029" title="ArkwrightPD , DavidTJ . Allergic disorders. In: McIntoshN , HelmsPJ , SmythRL , LoganS editor(s). Forfar and Arneil's Test Book of Paediatrics. 7th Edition. Churchill Livingstone, 2008:1519‐39. ">Arkwright 2008</a>). This immunological response may cause mild to severe reactions in different individuals and can be life threatening (<a href="./references#CD010085-bbs2-0029" title="ArkwrightPD , DavidTJ . Allergic disorders. In: McIntoshN , HelmsPJ , SmythRL , LoganS editor(s). Forfar and Arneil's Test Book of Paediatrics. 7th Edition. Churchill Livingstone, 2008:1519‐39. ">Arkwright 2008</a>). Thus allergy is an important public health problem which places a burden on individuals, society and the healthcare system (<a href="./references#CD010085-bbs2-0048" title="GuptaR , SheikhA , StrachanDP , AndersonHR . Burden of allergic disease in the UK: secondary analyses of national databases. Clinical and Experimental Allergy2004;34(4):520‐6. ">Gupta 2004</a>). </p> <p>Environmental factors seem to have had an important influence on the increasing incidence of allergies. Possible contributing factors include lack of breastfeeding, higher socio‐economic conditions with higher standards of hygiene, fewer respiratory infections, greater use of antibiotics early in life, fewer older siblings in the household, less contact with farm animals, general lack of microbial exposure and changes in dietary patterns (<a href="./references#CD010085-bbs2-0048" title="GuptaR , SheikhA , StrachanDP , AndersonHR . Burden of allergic disease in the UK: secondary analyses of national databases. Clinical and Experimental Allergy2004;34(4):520‐6. ">Gupta 2004</a>; <a href="./references#CD010085-bbs2-0087" title="StrongK , MathersC , LeederS , BeagleholeR . Preventing chronic diseases: how many lives can we save?. Lancet2005;366(9496):1578‐82. ">Strong 2005</a>). </p> <p>Among the changes in dietary patterns, it has been hypothesised that the balance of long chain polyunsaturated fatty acids (LCPUFA), specifically the n‐3 (omega 3) to n‐6 (omega 6) ratio, may be a factor in the increased incidence of childhood allergies (<a href="./references#CD010085-bbs2-0034" title="CalderPC , MilesEA . Fatty acids and atopic disease. Pediatrics Allergy and Immunology2000;13:29‐36. ">Calder 2000</a>; <a href="./references#CD010085-bbs2-0039" title="CalderPC , KremmydaLS , VlachavaM , NoakesPS , MilesEA . Is there a role for fatty acids in early life programming of the immune system?. Proceedings of the Nutrition Society2010;69(3):373‐80. [PUBMED: 20462467] ">Calder 2010b</a>; <a href="./references#CD010085-bbs2-0072" title="PrescottSL , CalderPC . N‐3 polyunsaturated fatty acids and allergic disease. Current Opinion in Clinical Nutrition and Metabolic Care2004;7:123‐9. ">Prescott 2004</a>). Furthermore, maternal fish consumption during pregnancy has also reduced due to precautionary public health advice regarding the consumption of specific fish which may contain methyl mercury (<a href="./references#CD010085-bbs2-0066" title="OkenE , KleinmanKP , BerlandWE , SimonSR , Rich‐EdwardsJW , GillmanMW , et al. Decline in fish consumption among pregnant women after a national mercury advisory. Obstetrics and Gynecology2003;102(2):346‐51. ">Oken 2003</a>). </p> </section> <section id="CD010085-sec-0024"> <h3 class="title" id="CD010085-sec-0024">Description of the intervention</h3> <p>Fish and fish oil are the major sources of n‐3 LCPUFA, while vegetable oils are the major source of n‐6 LCPUFA. Recent data suggest that dietary consumption of n‐3 LCPUFA has declined in Western diets to favour the intake of n‐6 fatty acids (<a href="./references#CD010085-bbs2-0062" title="MeyerBJ , MannNJ , LewisJL , MilliganGC , SinclairAJ , HowePR . Dietary intakes and food sources of omega‐6 and omega‐3 polyunsaturated fatty acids. Lipids2003;38(4):391‐8. ">Meyer 2003</a>). Epidemiological data suggest that a higher fish intake during pregnancy is associated with fewer symptoms of allergic diseases in the offspring in early childhood (<a href="./references#CD010085-bbs2-0040" title="CalvaniM , AlessandriC , SopoSM , PanettaV , PingitoreG , TripodiS , et al. Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy. Pediatric Allergy and Immunology2006;17(2):94‐102. ">Calvani 2006</a>; <a href="./references#CD010085-bbs2-0077" title="RomieuI , TorrentM , Garcia‐EstebanR , FerrerC , Ribas‐FitóN , AntóJM , et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clinical and Experimental Allergy2007;37(4):518‐25. ">Romieu 2007</a>; <a href="./references#CD010085-bbs2-0079" title="SausenthalerS , KoletzkoS , SchaafB , LehmannI , BorteM , HerbarthO , et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. American Journal of Clinical Nutrition2007;85(2):530‐7. ">Sausenthaler 2007</a>; <a href="./references#CD010085-bbs2-0089" title="WillersSM , DevereuxG , CraigLC , McNeillG , WijgaAH , Abou El‐MagdW , et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5‐year‐old children. Thorax2007;62(9):773‐9. ">Willers 2007</a>). Thus, supplementing maternal diets with n‐3 LCPUFA may be an important factor in reducing the incidence of allergic diseases. </p> </section> <section id="CD010085-sec-0025"> <h3 class="title" id="CD010085-sec-0025">How the intervention might work</h3> <p>Dietary n‐3 LCPUFA supplementation during pregnancy and lactation has been suggested to modulate the immune system of the fetus, neonate or infant before allergic responses are established (<a href="./references#CD010085-bbs2-0042" title="DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. ">Denburg 2005</a>). The early programming of fetal immune responses to allergens possibly begins in the epithelial tissue where antigen (allergen) proteins first encounter antigen‐presenting cells (<a href="./references#CD010085-bbs2-0073" title="PrescottSL , DunstanJA . Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids2007;42(9):801‐10. ">Prescott 2007</a>). The pattern of cytokine production by antigen‐presenting cells determines the pattern of T‐helper (Th) cells differentiation (<a href="./references#CD010085-bbs2-0073" title="PrescottSL , DunstanJA . Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids2007;42(9):801‐10. ">Prescott 2007</a>). T cells producing Type 1 T cells (Th1), develop under the influence of interleukin (IL)‐12 and IL‐2, whereas T cells producing Type 2 T cells (Th2), develop in the relative absence of pro‐Th2 factors such as IL‐4 (<a href="./references#CD010085-bbs2-0084" title="SnijdewintFG , KalinskiP , WierengaEA , BosJD , KapsenbergML . Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. Journal of Immunology1993;150(12):5321‐9. ">Snijdewint 1993</a>). The differences in T cell phenotypes also determine the pattern of B‐cell antibody production with Th2 cytokines (IL‐4, IL‐5, and IL‐13), prompting IgE production and allergic inflammation, whereas Th1 cytokines (IFN‐γ) largely inhibit this in favour of low level IgG production (<a href="./references#CD010085-bbs2-0036" title="CalderPC . n‐3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition2006;83(6):1505s‐19s. ">Calder 2006</a>; <a href="./references#CD010085-bbs2-0038" title="CalderPC . Does early exposure to long chain polyunsaturated fatty acids provide immune benefits?. Journal of Pediatrics2010;156(6):869‐71. ">Calder 2010a</a>). Th2 cytokines are also important in determining whether these immune responses result in clinically relevant diseases such as asthma, allergic rhinitis or allergic dermatitis (<a href="./references#CD010085-bbs2-0035" title="CalderPC . Polyunsaturated fatty acids and cytokine profiles: a clue to the changing prevalence of atopy?. Clinical and Experimental Allergy2003; Vol. 33, issue 4:412‐5. [PUBMED: 12680853] ">Calder 2003</a>; <a href="./references#CD010085-bbs2-0045" title="GeorasSN , GuoJ , DeFanisU , CasolaroV . T‐helper cell type‐2 regulation in allergic disease. European Respiratory Journal2005;26(6):1119‐37. ">Georas 2005</a>; <a href="./references#CD010085-bbs2-0073" title="PrescottSL , DunstanJA . Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids2007;42(9):801‐10. ">Prescott 2007</a>). A well regulated placental balance between the Th1 and Th2 responses is important for developing a robust immune system during pregnancy (<a href="./references#CD010085-bbs2-0088" title="WilczynskiJR . Th1/Th2 cytokines balance‐yin and yang of reproductive immunology. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122(2):136‐43. ">Wilczynski 2005</a>). </p> <p>Maternal n‐3 LCPUFA intervention studies support this immune programming hypothesis (<a href="./references#CD010085-bbs2-0021" title="BroekaertI , CampoyC , IznaolaC , HoffmanB , Mueller‐FelberW , KoletzkoBV . Visual evoked potentials in infants after dietary supply of docosahexaenoic acid and 5‐methyl‐tetrahydrofolate during pregnancy. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S33. CampoyC , Escolano‐MargaritMV , RamosR , Parrilla‐RoureM , CsabiG , BeyerJ , et al. Effects of prenatal fish‐oil and 5‐methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age. American Journal of Clinical Nutrition2011;94(6 Suppl):1880S‐8S. CampoyC , MarchalG , DecsiT , CruzM , SzaboE , DemmelmairH , et al. Spanish pregnant women's plasma phospholipids LC‐PUFAs concentrations and its influence on their newborns. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S11. DecsiT , CampoyC , KoletzkoB . Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy: the nuheal trial. Advances in Experimental Medicine and Biology2005;569:109‐13. DemmelmairH , KlinglerM , CampoyC , DecsiT , KoletzkoB . Low eicosapentaenoic acid concentrations in fish oil supplements do not influence the arachidonic acid contents in placental lipids. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S11. DemmelmairH , KlinglerM , CampoyC , DiazJ , DecsiT , VeszpremiB , et al. The influence of habitual diet and increased docosahexaenoic acid intake during pregnancy on the fatty acid composition of individual placental lipids [abstract]. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):622‐3. DolzV , CampoyC , MolloyA , ScottJ , MarchalG , DecsiT , et al. Homocysteine, folate &amp; methylenetetrahydrofolate reductase (MTHFR) 677 ‐ T poly‐morphism in Spanish pregnant woman and in their offspring [abstract]. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):623‐4. Escolano‐MargaritMV , CampoyC , Ramirez‐TortosaMC , DemmelmairH , MirandaMT , GilA , et al. Effects of fish oil supplementation on the fatty acid profile in erythrocyte membrane and plasma phospholipids of pregnant women and their offspring: a randomised controlled trial. British Journal of Nutrition2013;109(9):1614‐56. Escolano‐MargaritMV , RamosR , BeyerJ , CsabiG , Parrilla‐RoureM , CruzF , et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. Journal of Nutrition2011;141(6):1216‐23. KlinglerM , BlaschitzA , CampoyC , CanoA , MolloyAM , ScottJM , et al. The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. British Journal of Nutrition2006;96(1):182‐90. Krauss‐EtschmannS , HartlD , HeinrichJ , ThaqiA , PrellC , CampoyC , et al. Association between levels of toll‐like receptors 2 and 4 and CD14 mRNA and allergy in pregnant women and their offspring. Clinical Immunology2006;118(2‐3):292‐9. Krauss‐EtschmannS , HartlD , RzehakP , HeinrichJ , ShadidR , DelCarmen Ramirez‐TortosaM , et al. Decreased cord blood IL‐4, IL‐13, and CCR4 and increased TGF‐beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology2008;121(2):464‐70. Krauss‐EtschmannS , ShadidR , CampoyC , HosterE , DemmelmairH , JimenezM , et al. Effects of fish‐oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. American Journal of Clinical Nutrition2007;85(5):1392‐400. ">Krauss‐Etschmann 2007</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0059" title="LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with ω‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98:480‐7. ">Lee 2013</a>; <a href="./references#CD010085-bbs2-0076" title="RomeroVC , SomersEC , StolbergV , ClintonC , ChensueS , DjuricZ , et al. Developmental programming for allergy: a secondary analysis of the Mothers, Omega‐3, and Mental Health Study. American Journal of Obstetrics and Gynecology2013;208(4):316.e.1‐6. ">Romero 2013</a>). Two studies investigated Th1/Th2 related molecules in cord blood (<a href="./references#CD010085-bbs2-0056" title="Krauss‐EtschmannS , HartlD , RzehakP , HeinrichJ , ShadidR , Ramírez‐TortosaMDC , et al. Decreased cord blood IL‐4, IL‐13, and CCR4 and increased TGF‐beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology2008;121(2):464‐70. ">Krauss‐Etschmann 2008</a>; <a href="./references#CD010085-bbs2-0076" title="RomeroVC , SomersEC , StolbergV , ClintonC , ChensueS , DjuricZ , et al. Developmental programming for allergy: a secondary analysis of the Mothers, Omega‐3, and Mental Health Study. American Journal of Obstetrics and Gynecology2013;208(4):316.e.1‐6. ">Romero 2013</a>), and the other investigated cytokine production in children at two and a half years of age (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>). These studies showed that allergy‐related immune parameters were lower in the offspring of women who had n‐3 LCPUFA supplementation during pregnancy or lactation (<a href="./references#CD010085-bbs2-0056" title="Krauss‐EtschmannS , HartlD , RzehakP , HeinrichJ , ShadidR , Ramírez‐TortosaMDC , et al. Decreased cord blood IL‐4, IL‐13, and CCR4 and increased TGF‐beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology2008;121(2):464‐70. ">Krauss‐Etschmann 2008</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0076" title="RomeroVC , SomersEC , StolbergV , ClintonC , ChensueS , DjuricZ , et al. Developmental programming for allergy: a secondary analysis of the Mothers, Omega‐3, and Mental Health Study. American Journal of Obstetrics and Gynecology2013;208(4):316.e.1‐6. ">Romero 2013</a>). The other study also showed that maternal n‐3 LCPUFA supplementation during pregnancy was associated with balancing Th1/Th2 and modulating IFNγ and IL13 in infants (<a href="./references#CD010085-bbs2-0059" title="LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with ω‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98:480‐7. ">Lee 2013</a>). </p> <p>Supporting evidence from mechanistic (<a href="./references#CD010085-bbs2-0042" title="DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. ">Denburg 2005</a>; <a href="./references#CD010085-bbs2-0073" title="PrescottSL , DunstanJA . Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids2007;42(9):801‐10. ">Prescott 2007</a>) and small scale intervention studies show that allergy markers and allergy mechanisms are influenced by n‐3 LCPUFA (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0074" title="PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science (Lond)2007;113(10):409‐16. ">Prescott 2007a</a>). Also there were studies in which maternal or postnatal consumption of n‐3 LCPUFA through oily fish or fish oil had an effect on allergy outcomes in children (<a href="./references#CD010085-bbs2-0050" title="HodgeL , SalomeCM , PeatJK , HabyMM , XuanW , WoolcockAJ . Consumption of oily fish and childhood asthma risk. Medical Journal of Australia1996;164(3):137‐40. ">Hodge 1996</a>; <a href="./references#CD010085-bbs2-0077" title="RomieuI , TorrentM , Garcia‐EstebanR , FerrerC , Ribas‐FitóN , AntóJM , et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clinical and Experimental Allergy2007;37(4):518‐25. ">Romieu 2007</a>), as well as a transient effect on allergy outcomes (<a href="./references#CD010085-bbs2-0063" title="MihrshahiS , PeatJK , WebbK , OddyW , MarksGB , MellisCM . Effect of omega‐3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatric Allergy and Immunology2004;15(6):517‐22. ">Mihrshahi 2004</a>; <a href="./references#CD010085-bbs2-0065" title="OddyWH , deKlerkNH , KendallGE , MihrshahiS , PeatJK . Ratio of omega‐6 to omega‐3 fatty acids and childhood asthma. Journal of Asthma2004;41(3):319‐26. ">Oddy 2004</a>). </p> </section> <section id="CD010085-sec-0026"> <h3 class="title" id="CD010085-sec-0026">Why it is important to do this review</h3> <p>Allergy is an important public health problem that places a burden on individuals, society and healthcare costs (<a href="./references#CD010085-bbs2-0048" title="GuptaR , SheikhA , StrachanDP , AndersonHR . Burden of allergic disease in the UK: secondary analyses of national databases. Clinical and Experimental Allergy2004;34(4):520‐6. ">Gupta 2004</a>; <a href="./references#CD010085-bbs2-0054" title="KempAS . Atopic eczema: its social and financial costs. Journal of Paediatrics and Child Health1999;35(3):229‐31. ">Kemp 1999</a>; <a href="./references#CD010085-bbs2-0071" title="PawankerRCG , HolgateST , LockeyRF , editors. WAO White Book On Allergy. World Allergy Organization (WAO), 2011. ">Pawanker 2011</a>). Consequently, allergy prevention is a major global challenge (<a href="./references#CD010085-bbs2-0087" title="StrongK , MathersC , LeederS , BeagleholeR . Preventing chronic diseases: how many lives can we save?. Lancet2005;366(9496):1578‐82. ">Strong 2005</a>) and the World Allergy Organization (WAO) recommends that allergy preventative strategies are urgently needed (<a href="./references#CD010085-bbs2-0030" title="AsherI , Baena‐CagnaniC , BonerA , CanonicaGW , ChuchalinA , CustovicA , et al. World Allergy Organization guidelines for prevention of allergy and allergic asthma. International  Archives of Allergy and Immunology2004;135(1):83‐92. ">Asher 2004</a>). It is uncertain if n‐3 LCPUFA supplementation during pregnancy or lactation reduces allergic disease in children. For these reasons, we need clear evidence from intervention studies. Therefore, in this systematic review we aim to evaluate the effects of maternal n‐3 LCPUFA supplementation during pregnancy and/or lactation on allergy outcomes in children.The safety aspects of n‐3 LCPUFA also need to be considered; it is postulated that high doses of n‐3 LCPUFA may have antithrombotic antiplatelet properties which may lead to bleeding (<a href="./references#CD010085-bbs2-0083" title="SimopoulosAP . Omega‐3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition1991;54:438‐63. ">Simopoulos 1991</a>), as well as immune cell alterations which may have an effect on infections (<a href="./references#CD010085-bbs2-0037" title="CalderPC . Immunomodulation by omega‐3 fatty acids. Prostaglandins Leukotrine and Essential Fatty Acids2007;77(5–6):327–35. ">Calder 2007</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010085-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-sec-0027">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-sec-0135">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010085-sec-0027"></div> <p>To assess the effect of maternal n‐3 LCPUFA supplementation during pregnancy and/or lactation on the allergy outcomes of their children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010085-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-sec-0136">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010085-sec-0028"></div> <section id="CD010085-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010085-sec-0030"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) focusing on n‐3 LCPUFA supplementation of pregnant and/or lactating women (compared with placebo or no treatment) and assessed allergy outcomes of the infants or children. Quasi‐RCTs and RCTs using a cluster‐randomised design were eligible for inclusion but none were identified. Trials published in abstract form only were not identified for inclusion. In future updates we will only consider abstracts for inclusion if unpublished data can be obtained from the trails. Trials using a cross‐over design and trials examining biochemical outcomes only were not eligible for inclusion. </p> </section> <section id="CD010085-sec-0031"> <h4 class="title">Types of participants</h4> <p>Women and their children, with either a normal or high risk of developing allergic disease, were included. A fetus or a child with a first degree relative with medically diagnosed allergies, or a positive a SPT, or a positive radioallergosorbent test (RAST) was defined as being at high risk of allergies. Infants were also considered at high risk of allergies if their cord blood IgE level was above 0.70 IU/mL. </p> </section> <section id="CD010085-sec-0032"> <h4 class="title">Types of interventions</h4> <p>We considered all randomised comparisons of n‐3 LCPUFA supplementation given to pregnant or lactating women (either with or without arachidonic acid), with placebo or no supplementation as a control, regardless of dose regimens and duration of intervention. Trials in which fish was the intervention were included if appropriately controlled, for example, if the diet was appropriately adjusted to match the protein contribution of fish. </p> </section> <section id="CD010085-sec-0033"> <h4 class="title">Types of outcome measures</h4> <p>Primary outcome measures included children with allergy, including food allergy, atopic dermatitis (eczema), asthma/wheeze, allergic rhinitis (hay fever) or any allergies (children with one or more of the allergy types). Outcomes were assessed as short term (occurring at less than 12 months of age), medium term (occurring from 12 to less than 36 months of age) and long term (36 months of age and older). Outcomes were also assessed by combining short‐term, medium‐term and long‐term results to assess the cumulative incidence. </p> <section id="CD010085-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010085-list-0001"> <li> <p>Medically diagnosed any allergy with sensitisation, i.e. IgE‐mediated allergies where both the signs and symptoms of the allergic disease and a positive SPT and/or RAST test are present. </p> </li> <li> <p>Medical diagnosis or parental report (using validated questionnaire) of any allergy, +/‐ IgE sensitisation. </p> </li> </ol> </p> </section> <section id="CD010085-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcome measures included children with specific forms of allergy, including food allergy, atopic dermatitis (eczema), asthma/wheeze, allergic rhinitis (hay fever) with IgE sensitisation and +/‐ IgE sensitisation, SPT results, and parent‐reported allergies using non‐validated questionnaires. Secondary safety outcomes included infant safety (e.g. infections) and maternal safety (e.g. postpartum haemorrhage or infection) due to the theoretical risk associated with higher doses of n‐3 LCPUFA. </p> </section> </section> </section> <section id="CD010085-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD010085-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (6 August 2014). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD010085-list-0002"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> <p>In addition, we searched PubMed (1966 to 01 August 2014) (<a href="./appendices#CD010085-sec-0113">Appendix 1</a>), CINAHL via EBSCOhost (1984 to 01 August 2014) (<a href="./appendices#CD010085-sec-0114">Appendix 2</a>), Scopus (1995 to 01 August 2014) (<a href="./appendices#CD010085-sec-0115">Appendix 3</a>), Web of Knowledge (1864 to 01 August 2014) (<a href="./appendices#CD010085-sec-0116">Appendix 4</a>) and <a href="http://clinicaltrials.gov/ct2/home" target="_blank">ClinicalTrials.gov</a> (01 August 2014) (<a href="./appendices#CD010085-sec-0117">Appendix 5</a>). </p> </section> <section id="CD010085-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD010085-sec-0039"> <h3 class="title" id="CD010085-sec-0039">Data collection and analysis</h3> <section id="CD010085-sec-0040"> <h4 class="title">Selection of studies</h4> <p>Two review authors Anoja W Gunaratne (AWG) and Carmel T Collins (CTC) independently assessed the eligibility of trials identified by the search. Disagreements were resolved through discussion or, if required, by consultation with the third review author Maria Makrides (MM). </p> </section> <section id="CD010085-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AWG, CTC) independently extracted the data from eligible trials using the agreed form. Discrepancies were resolved through discussion or through consultation with the third author (MM) if required. When information was unclear or incomplete, we attempted to contact authors of the original reports to provide further details. We entered data into Review Manager software 5.3 (<a href="./references#CD010085-bbs2-0075" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked them for accuracy. </p> </section> <section id="CD010085-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AWG, CTC) independently assessed the risk of bias for each trial using the criteria outlined in<i>the Cochrane Handbook for Systematic Reviews of Interventions (Handbook) (</i><a href="./references#CD010085-bbs2-0049" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a><i>).</i> We resolved any disagreement by discussion or by involving a third assessor (MM). MM and CTC are Investigators on two trials, <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> and <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> included in the review. These trials were independently assessed for risk of bias and data extracted by AWG and an independent researcher third party Karen Best (KB). </p> <section id="CD010085-sec-0043"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>For each included trial, we described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it would produce comparable groups. </p> <p>We assessed the method as:</p> <p>low risk of bias (any truly random process, e.g. random number table, computer random number generator); high risk of bias (any non‐random process, e.g. odd or even date of birth, hospital or clinic record number); unclear risk of bias. </p> </section> <section id="CD010085-sec-0044"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included trial, we described the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen before recruitment, during recruitment or changed after assignment. </p> <p>We assessed the methods as:</p> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); unclear risk of bias. </p> </section> <section id="CD010085-sec-0045"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described the methods used, if any, to blind trial participants and personnel from knowledge of which intervention a participant received for each trial. We considered that trials were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p>low, high or unclear risk of bias for participants; low, high or unclear risk of bias for personnel. </p> </section> <section id="CD010085-sec-0046"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received for each included trial. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods used to blind outcome assessment as:</p> <p>low, high or unclear risk of bias.</p> </section> <section id="CD010085-sec-0047"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described the completeness of data, including attrition and exclusions from the analysis, for each included trial and for each outcome or class of outcomes. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants). We also outlined the reasons for attrition or exclusion, where reported, and whether missing data were balanced across groups or related to outcomes. We included missing data in the analyses where sufficient information was reported or could be supplied by the trial authors. </p> <p>We assessed methods as:</p> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); unclear risk of bias. </p> </section> <section id="CD010085-sec-0048"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described our investigation of possible selective outcome reporting bias and our results for each included trial. </p> <p>We assessed the methods as having a:</p> <p>low risk of bias – where it is clear that all of the trial’s pre‐specified outcomes and all expected outcomes of interest to the review were reported; high risk of bias – where not all the trial’s pre‐specified outcomes had been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; or trial failed to include results of a key outcome that would have been expected to have been reported; unclear risk of bias. </p> </section> <section id="CD010085-sec-0049"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described any important concerns we had about other possible sources of bias for each included trial. </p> <p>We assessed whether each trial was free of other problems that could put it at risk of bias, as low, high or unclear risk of other bias. </p> </section> <section id="CD010085-sec-0050"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether trials were at high risk of bias according to the criteria given in the <i>Handbook</i> (<a href="./references#CD010085-bbs2-0049" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses – <i>see</i><a href="#CD010085-sec-0064">Sensitivity analysis</a>. </p> </section> </section> <section id="CD010085-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <section id="CD010085-sec-0052"> <h5 class="title">Dichotomous data</h5> <p>Results are presented as summary risk ratio with 95% confidence intervals.</p> </section> <section id="CD010085-sec-0053"> <h5 class="title">Continuous data</h5> <p>We planned to present the results of continuous data as the mean difference, if outcomes were measured in the same way between trials. We would have used the standardised mean difference to combine trials that measured the same outcome but used different methods. </p> </section> </section> <section id="CD010085-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <section id="CD010085-sec-0055"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion in this review. If we identify cluster‐randomised trials in future updates of this review, we will include them in the analyses along with individually‐randomised trials. We will adjust their sample size using the methods described in the <i>Handbook</i> (<a href="./references#CD010085-bbs2-0049" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a trial of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we will synthesis the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the trial designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD010085-sec-0056"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are not an appropriate design for this review.</p> </section> <section id="CD010085-sec-0057"> <h5 class="title">Other unit of analysis issues</h5> <section id="CD010085-sec-0058"> <h6 class="title">Trials with more than two treatment groups</h6> <p>Trials using one or more treatment groups (multi‐arm trials) were combined to create a single pair‐wise comparison where appropriate. We used the methods described in the <i>Handbook</i> (<a href="./references#CD010085-bbs2-0049" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to ensure that we did not double count participants. </p> </section> </section> </section> <section id="CD010085-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We noted levels of attrition within the included trials. We used sensitivity analyses to explore the impact of including trials with high levels of missing data on the overall assessment of treatment effect. For all outcomes, we carried out analyses (as far as possible) on an intention‐to‐treat basis. This meant that we attempted to include all participants randomised to each group in the analyses with all participants analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator used for each outcome was the number randomised minus the number with missing outcomes. In studies where there were missing data, we imputed results, if the imputed results differed little from the raw data. </p> </section> <section id="CD010085-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the T² was greater than zero or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD010085-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD010085-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analyses using the Review Manager software 5.2 (<a href="./references#CD010085-bbs2-0075" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that trials were estimating the same underlying treatment effect: that is, where trials were examining the same intervention and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. We did not combine trials if the average treatment effect was not clinically meaningful. </p> <p>Where we used random‐effects analyses, the results are presented as the average treatment effect with 95% confidence intervals and estimates of T² and I². </p> </section> <section id="CD010085-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Substantial heterogeneity was investigated using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, used random‐effects analyses. </p> <p>We planned to carry out the following subgroup analyses.</p> <p> <ol id="CD010085-list-0003"> <li> <p>Timing of supplementation</p> <ol id="CD010085-list-0004"> <li> <p>n‐3 LCPUFA supplementation during pregnancy versus placebo or no supplementation during pregnancy </p> </li> <li> <p>n‐3 LCPUFA supplementation during lactation versus placebo or no supplementation during lactation </p> </li> <li> <p>n‐3 LCPUFA supplementation during pregnancy and lactation versus placebo or no supplementation during pregnancy and lactation </p> </li> </ol> </li> <li> <p>Allergy risk</p> <ol id="CD010085-list-0005"> <li> <p>Maternal n‐3 LCPUFA supplementation in women whose infants were at high risk of allergic disease versus placebo or no supplementation </p> </li> <li> <p>Maternal n‐3 LCPUFA supplementation in women whose infants were not considered as at high risk of allergic disease versus placebo or no supplementation </p> </li> </ol> </li> <li> <p>Infant maturity</p> <ol id="CD010085-list-0006"> <li> <p>Maternal n‐3 LCPUFA supplementation in term born infants versus placebo or no supplementation</p> </li> <li> <p>Maternal n‐3 LCPUFA supplementation in preterm born infants versus placebo or no supplementation</p> </li> </ol> </li> </ol> </p> <p>We restricted subgroup analyses to the primary outcomes.</p> </section> <section id="CD010085-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analyses for the review's primary outcomes to investigate the effect of trial quality by removing those trials rated as ‘high' or 'unclear' risk of selection, performance or attrition bias to establish whether it was likely to impact on the findings. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010085-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010085-sec-0065"></div> <section id="CD010085-sec-0066"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010085-sec-0127" title="">Characteristics of included studies</a>; <a href="./references#CD010085-sec-0128" title="">Characteristics of excluded studies</a>. </p> <section id="CD010085-sec-0067"> <h4 class="title">Results of the search</h4> <p>Electronic searches yielded 2290 records. The Cochrane Pregnancy and Childbirth Trials Register search (06 August 2014), retrieved 144 reports. Other electronic databases, PubMed (1966 to 01 August 2014), CINAHL via EBSCOhost (1984 to 01 August 2014), Scopus (1995 to 01 August 2014), Web of Knowledge (1864 to 01 August 2014) and <a href="http://clinicaltrials.gov/ct2/home" target="_blank">ClinicalTrials.gov</a> (01 August 2014) retrieved 159, 18,1817, 140 and 12 reports respectively. Two additional reports included the doctoral thesis (submitted) of AWG and an unpublished honours dissertation supervised by MM and CTC. </p> <p>Of the 2292 records, we removed duplicates and irrelevant reports and identified 141 titles and abstracts by considering the inclusion criteria. Sixteen trials (with 43 reports) were excluded, leaving eight trials (with 94 reports) for inclusion in this review. Four trials (with four reports) are ongoing (<a href="./references#CD010085-bbs2-0025" title="BisgaardH . Fish oil supplementation during pregnancy for prevention of asthma, eczema and allergies in childhood: interventional trial in the cCOPSAC2010 (Copenhagen studies on asthma in childhood) birth cohort. http://clinicaltrials.gov/ct2/show/NCT00798226 (accessed 15 September 2012). ">Bisgaard 2012</a>; <a href="./references#CD010085-bbs2-0026" title="DuchenK . Combined dietary supplementation with lactobacillus reuteri and omega‐3 PUFA during pregnancy and postnatally in relation to development of IgE‐associated disease during infancy. http://clinicaltrials.gov/ct2/show/NCT01542970 (accessed 15 September 2012). ">Duchen 2012</a>; <a href="./references#CD010085-bbs2-0027" title="LaitinenK . Nutrition and pregnancy intervention study. ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT01922791) (accessed 5 February 2014). NCT01922791 2013. ">Laitinen 2013</a>; <a href="./references#CD010085-bbs2-0028" title="LiuZ , YinH . The effect of polyunsaturated fatty acids (PUFA) on allergic/atopic dermatitis. http://clinicaltrials.gov/ct2/show/NCT01936194 (verified September 2013) 2014. ">Liu 2013</a>.) See <a href="#CD010085-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010085-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010085-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010085-sec-0068"> <h4 class="title">Included studies</h4> <p>See: <a href="./references#CD010085-sec-0127" title="">Characteristics of included studies</a>. </p> <p>We identified eight randomised controlled trials with 3366 women (3175 children) who were supplemented with oily fish, or n‐3 LCPUFA supplements during pregnancy and/or during lactation and assessed allergic outcomes in their children. </p> <section id="CD010085-sec-0069"> <h5 class="title">Study design</h5> <p>All eight trials were parallel randomised controlled trials published in English. Six trials had two parallel groups (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), one trial included two parallel groups and a high fish intake non‐randomised reference group (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>), and one trial had three parallel groups including intervention, placebo and no oil group (<a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>). </p> <p>Full details of the included trials are provided in the <a href="./references#CD010085-sec-0127" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD010085-sec-0070"> <h5 class="title">Participants</h5> <p>Of the 3366 women included in the review, 667 were supplemented during the postnatal period only (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>), 145 received supplementation in both the prenatal and postnatal period (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>) and the remaining 2554 women were only supplemented in the prenatal period (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). Women with a fetus at high risk of allergies (n = 1072) were included in four trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) while the remainder included women with a fetus at both high and normal risk of allergies (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), see 'types of participants for definition of high risk'. In one trial, only preterm infants were included (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>). </p> </section> <section id="CD010085-sec-0071"> <h5 class="title">Sample sizes</h5> <p>The sample sizes of the included trials ranged from 98 (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>) to 1094 (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). Four trials had approximately 100 to 150 mothers (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) and four trials had &gt; 500 participants (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). </p> </section> <section id="CD010085-sec-0072"> <h5 class="title">Study location</h5> <p>Three trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) were undertaken in Australia, two (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>) in Denmark, one (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>) in Sweden, one (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) in Mexico, and one (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) in the UK. Most of the trials were conducted in high‐income, well‐developed industrialised countries except one trial (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) which was conducted in a upper‐middle income country. </p> </section> <section id="CD010085-sec-0073"> <h5 class="title">Intervention</h5> <p>Six trials used n‐3 LCPUFA capsules (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), one used muesli bars containing microencapsulated fish oil as a source of n‐3 LCPUFA (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>), and the remaining trial used oily fish (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>). The daily dosage of n‐3 LCPUFA varied between 400 mg and 4500 mg; providing between 331 mg and 2070 mg of docosahexaenoic acid (DHA) and 100 mg and 1600 mg of eicosapentaenoic acid (EPA). Control groups received olive oil in three trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>), soy oil in two trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>), a blend of vegetable oils (rapeseed, sunflower, and palm in equal proportions) in one trial, (<a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), or a blend of corn and soy oil in one trial (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a> included a third randomised group who did not receive any supplementation and the control group in <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a> also received no supplementation. </p> <p>The prenatal supplementation trials commenced supplementation between 18 to 20 weeks (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), at 20 (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) and 30 (<a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>) weeks of gestation and continued until delivery. One trial supplemented in both the prenatal and postnatal period, commencing from 25 weeks' gestation and continuing until the infant reached four months of age (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>). In the two postnatal supplementation trials, supplementation commenced within one week after delivery (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>). The duration of supplementation was four months in <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a> while in <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> trial in preterm infants, supplementation continued until the infant reached 40 weeks postmenstrual age (a median duration of 9.4 weeks supplementation). </p> </section> <section id="CD010085-sec-0074"> <h5 class="title">Outcome measures</h5> <p>The allergy outcomes were determined by parental reports of doctor diagnosed allergy in one trial (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>), parental reports of allergy symptoms in one trial (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) and parental reports of allergy symptoms and parental reports of doctor diagnosed allergy in one trial (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>). Allergy was medically diagnosed in the remaining trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). In <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>, the medical diagnosis of allergy was obtained from the Danish Medical registries. Parent reports of allergy outcome data were collected using a non‐validated questionnaire and validated International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire in <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> trial. Parent reports of allergy outcome data were collected using a non‐validated questionnaire in <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a> trial. Additionally, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> trial also had parent reports of allergy outcome data using a non‐validated questionnaire. The data that were collected using non‐validated questionnaires were only included in the secondary outcomes. </p> <p>The age of assessments differed in the trials. Assessments were conducted at one month and three months (<a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), six months (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), 12 months (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), 18 months corrected age (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), 24 months (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>), 30 months (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>), three to five years corrected age (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>) (subgroup), 36 months (<a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), seven years of age (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>), and 16 years of age (<a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>). Of the five trials that used medical diagnosis of allergies (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), four performed skin prick tests (SPT) (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) and included children at high risk of allergy. Two trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) reported SPT results for children under 12 months of age, three trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), reported SPT between 12 to 36 months of age, and one trial (<a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported SPT in children at 36 months of age. </p> <p>IgE‐mediated allergies were reported in <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a> and <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>. Two trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) used blood samples for IgE detection in infants and one trial (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) reported the results at birth and six months of age while the other trial (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>) analysed the serum IgE levels at three and 12 months of age, but results were not reported. </p> <p>The type of allergies reported in the trials differed. Five trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported food allergy. Six trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported eczema. All trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) reported asthma or wheeze. Three trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported allergic rhinitis and four trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported any allergy. </p> <p>Two trials (<a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) reported postpartum haemorrhage. <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> (n = 2399) was the primary trial from which the <a href="./references#CD010085-bbs2-0069" title="PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. ">Palmer 2012</a> participants were recruited (see table of included studies); the incidence of postpartum haemorrhage is reported for the primary trial. Four trials (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) reported early childhood infections. Infection outcomes (in‐hospital proven late onset sepsis) for <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> are reported for the whole sample (n = 657). <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a> also reported fever in infants. </p> </section> </section> <section id="CD010085-sec-0075"> <h4 class="title">Excluded studies</h4> <p>See: <a href="./references#CD010085-sec-0128" title="">Characteristics of excluded studies</a>. </p> <p>We excluded 16 randomised controlled trials where the intervention was n‐3 LCPUFA supplementation but allergy outcomes of the infants and/or children were not reported (<a href="./references#CD010085-bbs2-0009" title="BergmannRL , BergmannKE , RichterR , Haschke‐BecherE , HenrichW , DudenhausenJW . Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six‐year follow‐up of a prospective randomized double‐blind monocenter study on low‐dose DHA supplements. Journal of Perinatal Medicine2012;40:677‐84. BergmannRL , Haschke‐BecherE , Klassen‐WiggerP , BergmannKE , RichterR , DudenhausenJW , et al. Supplementation with 200 mg/day docosahexaenoic acid from mid‐pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Annals of Nutrition and Metabolism2008;52(2):157‐66. BergmannRL , Haschke‐Becher , BergmannKE , DudenhausenJW , HaschkeF . Low dose docosahexaenoic acid supplementation improves the DHA status of pregnant women [abstract]. Pediatric Academic Societies Annual Meeting; 2006 April 29‐May 2; San Francisco, CA, USA. 2006. BergmannRL , RichterR , BergmannKE , DudenhausenJW , HaschkeF . 21 months old infants are leaner if their mothers received low dose DHA supplements during pregnancy and lactation. European Journal of Pediatrics2006;165 Suppl 1:114. ">Bergmann 2008</a>; <a href="./references#CD010085-bbs2-0010" title="Campos‐MartinezA , Serrano‐L , Medina‐M , Ochoa‐J , Pena‐CaballeroM . Levels of docosahexaenoic acid in pregnant women and their children after taking a fish oil enriched diet. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(S2):92. ">Campos‐Martinez 2012</a>; <a href="./references#CD010085-bbs2-0011" title="CarlsonSE . DHA supplementation and pregnancy outcome. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 21 March 2006]2006. CarlsonSE , ColomboJ , GajewskiBJ , GustafsonKM , MundyD , YeastJ , et al. DHA supplementation and pregnancy outcomes. American Journal of Clinical Nutrition2013;97(4):808–15. ">Carlson 2013 </a>: <a href="./references#CD010085-bbs2-0012" title="ColomboJ , KannassKN , ShaddyDJ , KundurthiS , MaikranzJM , AndersonCJ , et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Development2004;75(4):1254‐67. ">Colombo 2004</a>; <a href="./references#CD010085-bbs2-0013" title="CourvilleAB , HarelO , Lammi‐KeefeCJ . Consumption of a DHA‐containing functional food during pregnancy is associated with lower infant ponderal index and cord plasma insulin concentration. British Journal of Nutrition2011;106(2):208‐12. ">Courville 2011</a>; <a href="./references#CD010085-bbs2-0014" title="GranotE , JakobovichE , RabinowitzR , LevyP , SchlesingerM . DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response. Mediators of Inflammation2011;2011:493925. ">Granot 2011</a>; <a href="./references#CD010085-bbs2-0015" title="BrunnerS , SchmidD , HuttingerK , MuchD , BruderlM , SedlmeierEM , et al. Effect of a dietary intervention to reduce the n‐6/n‐3 fatty acid ratio on the maternal and cord blood leptin axis and relation of leptin to body composition in the offspring ‐ Results of the infat‐study (pepo‐consortium of the competence network obesity). Obesity Facts2012;5(Suppl 2):10. HaunerH , MuchD , VollhardtC , BrunnerS , SchmidD , SedlmeierEM , et al. Effect of reducing the n‐6:n‐3 long‐chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: An open‐label randomized controlled trial. American Journal of Clinical Nutrition2012;95(2):383‐94. HaunerH , VollhardtC , SchneiderKT , ZimmermannA , SchusterT , Amann‐GassnerU . The impact of nutritional fatty acids during pregnancy and lactation on early human adipose tissue development. Rationale and design of the INFAT study. Annals of Nutrition and Metabolism2009;54(2):97‐103. MuchD , BrunnerS , VollhardtC , SchmidD , SedlmeierEM , BruderlM , et al. Effect of dietary intervention to reduce the n‐6/n‐3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. European Journal of Clinical Nutrition2013;67(3):282‐8. ">Hauner 2009</a>; <a href="./references#CD010085-bbs2-0016" title="HellandIB , SaaremK , SaugstadOD , DrevonCA . Fatty acid composition in maternal milk and plasma during supplementation with cod liver oil. European Journal of Clinical Nutrition1998;52(11):839‐45. HellandIB , SaugstadOD , SaaremK , VanHouwelingenAC , NylanderG , DrevonCA . Supplementation of n‐3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. Journal of Maternal‐Fetal and Neonatal Medicine2006;19(7):397‐406. HellandIB , SaugstadOD , SmithL , SaaremK , SolvollK , GanesT , et al. Similar effects on infants of n‐3 and n‐6 fatty acids supplementation to pregnant and lactating women. Pediatrics2001;108(5):E82. HellandIB , SmithL , BlomenB , SaaremK , SaugstadOD , DrevonCA . Effect of supplementing pregnant and lactating mothers with n‐3 very‐long‐chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics2008;122(2):e472‐9. HellandIB , SmithL , SaaremK , SaugstadOD , DrevonCA . Maternal supplementation with very‐long‐chain n‐3 fatty acids during pregnancy and lactation augments children's iq at 4 years of age. Pediatrics2003;111(1):e39‐44. ">Helland 2001</a>; <a href="./references#CD010085-bbs2-0017" title="InnisSM . N‐3 fatty acid requirements for human development. http://clinicaltrials.gov/ct2/show/NCT00620672 (accessed 9 April 2008). InnisSM , FriesenRW . Essential N‐3 fatty acids in pregnant women and early visual acuity maturation in term infants. American Journal of Clinical Nutrition2008;87(3):548‐57. InnisSM , FriesenRW . Maternal DHA supplementation in pregnancy: a double blind randomized prospective trial of maternal N‐3 fatty acid status, human milk fatty acids and infant development. Pediatric Academic Societies Annual Meeting; 2007 May 5‐8; Toronto, Canada. 2007. MulderKA , InnisSM , RichardsonKJ . Cognitive performance of children 5‐6 years of age is associated with children's docosahexaenoic acid (DHA), but not dietary DHA or maternal DHA in pregnancy. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2014 May 3‐6; Vancouver, Canada. 2014:Abstract no: 3680.6. MulderKA , KingDJ , InnisSM . Omega‐3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. Plos One2014;9(1):e83764. ">Innis 2007</a>; <a href="./references#CD010085-bbs2-0018" title="JudgeMP , HarelO , Lammi‐KeefeCJ . A docosahexaenoic acid‐functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids2007;42(2):117‐22. ">Judge 2007</a>; <a href="./references#CD010085-bbs2-0019" title="KarlssonT , Birberg‐ThornbergU , DuchenK , GustafssonPA . LC‐PUFA supplemented to mothers during pregnancy and breast‐feeding improves cognitive performance in their children four years later ‐ an rct study. 9th Congress of the ISSFAL; 29 May‐2 June 2010; Maastricht, The Netherlands2010:113. ">Karlsson 2010</a>; <a href="./references#CD010085-bbs2-0020" title="KnudsenVK , HansenHS , OsterdalML , MikkelsenTB , MuH , OlsenSF . Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2006;113(5):536‐43. ">Knudsen 2006</a>; <a href="./references#CD010085-bbs2-0021" title="BroekaertI , CampoyC , IznaolaC , HoffmanB , Mueller‐FelberW , KoletzkoBV . Visual evoked potentials in infants after dietary supply of docosahexaenoic acid and 5‐methyl‐tetrahydrofolate during pregnancy. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S33. CampoyC , Escolano‐MargaritMV , RamosR , Parrilla‐RoureM , CsabiG , BeyerJ , et al. Effects of prenatal fish‐oil and 5‐methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age. American Journal of Clinical Nutrition2011;94(6 Suppl):1880S‐8S. CampoyC , MarchalG , DecsiT , CruzM , SzaboE , DemmelmairH , et al. Spanish pregnant women's plasma phospholipids LC‐PUFAs concentrations and its influence on their newborns. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S11. DecsiT , CampoyC , KoletzkoB . Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy: the nuheal trial. Advances in Experimental Medicine and Biology2005;569:109‐13. DemmelmairH , KlinglerM , CampoyC , DecsiT , KoletzkoB . Low eicosapentaenoic acid concentrations in fish oil supplements do not influence the arachidonic acid contents in placental lipids. Journal of Pediatric Gastroenterology and Nutrition2004;39(Suppl 1):S11. DemmelmairH , KlinglerM , CampoyC , DiazJ , DecsiT , VeszpremiB , et al. The influence of habitual diet and increased docosahexaenoic acid intake during pregnancy on the fatty acid composition of individual placental lipids [abstract]. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):622‐3. DolzV , CampoyC , MolloyA , ScottJ , MarchalG , DecsiT , et al. Homocysteine, folate &amp; methylenetetrahydrofolate reductase (MTHFR) 677 ‐ T poly‐morphism in Spanish pregnant woman and in their offspring [abstract]. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):623‐4. Escolano‐MargaritMV , CampoyC , Ramirez‐TortosaMC , DemmelmairH , MirandaMT , GilA , et al. Effects of fish oil supplementation on the fatty acid profile in erythrocyte membrane and plasma phospholipids of pregnant women and their offspring: a randomised controlled trial. British Journal of Nutrition2013;109(9):1614‐56. Escolano‐MargaritMV , RamosR , BeyerJ , CsabiG , Parrilla‐RoureM , CruzF , et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. Journal of Nutrition2011;141(6):1216‐23. KlinglerM , BlaschitzA , CampoyC , CanoA , MolloyAM , ScottJM , et al. The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. British Journal of Nutrition2006;96(1):182‐90. Krauss‐EtschmannS , HartlD , HeinrichJ , ThaqiA , PrellC , CampoyC , et al. Association between levels of toll‐like receptors 2 and 4 and CD14 mRNA and allergy in pregnant women and their offspring. Clinical Immunology2006;118(2‐3):292‐9. Krauss‐EtschmannS , HartlD , RzehakP , HeinrichJ , ShadidR , DelCarmen Ramirez‐TortosaM , et al. Decreased cord blood IL‐4, IL‐13, and CCR4 and increased TGF‐beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology2008;121(2):464‐70. Krauss‐EtschmannS , ShadidR , CampoyC , HosterE , DemmelmairH , JimenezM , et al. Effects of fish‐oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. American Journal of Clinical Nutrition2007;85(5):1392‐400. ">Krauss‐Etschmann 2007</a>; <a href="./references#CD010085-bbs2-0022" title="Martin‐AlvarezE , Guerrero‐MontenegroB , Romero‐PaniaguaMT , Lara‐VillosladaF , Hurtado‐SuazoJA . Maternal docosahexaenoic acid supplementation during pregnancy and lactation can modulate oxidative stress in the term newborn. Journal of Maternal‐Fetal and Neonatal Medicine2012;25(S2):40. ">Martin‐Alvarez 2012</a>: <a href="./references#CD010085-bbs2-0023" title="Pena‐QuintanaL , PenaM , Rodriguez‐SantanaY , HurtadoJA , OchoaJ , SanjurjoP , et al. Consumption of a dairy product enriched with fish oil during pregnancy maintains the dha status of the mother and increase dha concentration in cord blood. Journal of Pediatric Gastroenterology and Nutrition2011;52(Suppl 1):E84. ">Pena‐Quintana 2011</a>; <a href="./references#CD010085-bbs2-0024" title="RibeiroP , CarvalhoFD , Abreu AdeA , Sant'anna MdeT , LimaRJ , Carvalho PdeO . Effect of fish oil supplementation in pregnancy on the fatty acid composition of erythrocyte phospholipids and breast milk lipids. International Journal of Food Sciences and Nutrition2012;63(1):36‐40. ">Ribeiro 2012</a>). Many of these trials are included in the Cochrane Systematic Review currently being updated (<a href="./references#CD010085-bbs2-0060" title="MakridesM , DuleyL , OlsenSF . Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre‐eclampsia or intrauterine growth restriction. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD003402.pub2] ">Makrides 2006</a>). </p> <section id="CD010085-sec-0076"> <h5 class="title">Characteristics of ongoing studies</h5> <p>See: <a href="./references#CD010085-sec-0129" title="">Characteristics of ongoing studies</a>. </p> <p>There are four ongoing trials (<a href="./references#CD010085-bbs2-0025" title="BisgaardH . Fish oil supplementation during pregnancy for prevention of asthma, eczema and allergies in childhood: interventional trial in the cCOPSAC2010 (Copenhagen studies on asthma in childhood) birth cohort. http://clinicaltrials.gov/ct2/show/NCT00798226 (accessed 15 September 2012). ">Bisgaard 2012</a>; <a href="./references#CD010085-bbs2-0026" title="DuchenK . Combined dietary supplementation with lactobacillus reuteri and omega‐3 PUFA during pregnancy and postnatally in relation to development of IgE‐associated disease during infancy. http://clinicaltrials.gov/ct2/show/NCT01542970 (accessed 15 September 2012). ">Duchen 2012</a>; <a href="./references#CD010085-bbs2-0027" title="LaitinenK . Nutrition and pregnancy intervention study. ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT01922791) (accessed 5 February 2014). NCT01922791 2013. ">Laitinen 2013</a>; <a href="./references#CD010085-bbs2-0028" title="LiuZ , YinH . The effect of polyunsaturated fatty acids (PUFA) on allergic/atopic dermatitis. http://clinicaltrials.gov/ct2/show/NCT01936194 (verified September 2013) 2014. ">Liu 2013</a>). </p> </section> </section> </section> <section id="CD010085-sec-0077"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, the eight included studies had various levels of risk of bias for methodological quality. See <a href="#CD010085-fig-0002">Figure 2</a> and <a href="#CD010085-fig-0003">Figure 3</a> for details. </p> <div class="figure" id="CD010085-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010085-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010085-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010085-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010085-sec-0078"> <h4 class="title">Allocation</h4> <p>All of the eight trials were at low risk of bias for sequence generation.</p> <p>Six trials reported adequate allocation concealment methods (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>: <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>) and two trials (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) had an unclear risk of bias as the method of allocation concealment was not described. </p> </section> <section id="CD010085-sec-0079"> <h4 class="title">Blinding</h4> <p>Women, care providers and research personnel were blinded in six trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). In two trials (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>), women who were randomised to the 'no supplement' group could not be blinded. </p> <p>Outcome assessments were performed by assessors who were blinded to the trial supplementations in all eight trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>: <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). </p> </section> <section id="CD010085-sec-0080"> <h4 class="title">Incomplete outcome data</h4> <p>All trials reported withdrawals and dropouts. We assessed four trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>: <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) as having a low risk of attrition bias. <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> reported 6% of participant losses to follow‐up at 18 months, 8% at three to five years of age and 10.5% at seven years of age. <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a> reported 1% of participant losses to follow‐up at 16 years of age. <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> reported participant follow‐up losses of 3.5% and 9.6% at one and three years of age respectively. <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a> reported 25% participants losses to follow‐up at six months, but balanced between group, and reasons for withdrawals were reported (intervention (23%) and control (24%)). <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a> and <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a> were assessed as having a high risk of attrition bias. <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a> reported a loss of 15% to follow‐up and participant exclusion after randomisation, which differed between intervention (n = 12, 23%) and control (n = 3, 6.5%). More women in the intervention group discontinued treatment because of nausea (n = 7, 13.5%) than in the control (n = 1, 2%). <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a> reported a 19% loss of participants to follow‐up (n = 16), with 23% in the treatment group (n = 9) and 12% in the placebo group excluded from the analysis because they did not complete the 15‐week intervention. <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a> had large follow‐up losses of more than 47%, with no reasons reported for the withdrawals (treatment n = 25, 40%; control n = 32, 53%). <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a> also had large follow‐up losses (30%) at six months with no reasons reported (treatment n = 16, 23%; control n = 23, 37%). </p> </section> <section id="CD010085-sec-0081"> <h4 class="title">Selective reporting</h4> <p>All trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>) except two (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) were assessed as having a high risk of reporting bias, as expected outcomes of interest to this review were not reported or were not reported completely. </p> </section> <section id="CD010085-sec-0082"> <h4 class="title">Other potential sources of bias</h4> <p>There were no obvious other potential sources of bias identified in four trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). There was an unclear risk of bias in the two trials that included subgroups of their original trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). In <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a> the placebo group and no oil group were combined in this review. We conducted analyses with the n‐3 LCPUFA supplementation group compared to olive oil control group separately to n‐3 LCPUFA supplementation group compared to no supplement control group, and found that although the direction of effect differed it made little difference to the meta‐analysis therefore for this review the control groups were combined. <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a> was rated as having an unclear risk of bias because preterm infants were excluded from their analysis after randomisation. </p> </section> </section> <section id="CD010085-sec-0083"> <h3 class="title" id="CD010085-sec-0083">Effects of interventions</h3> <section id="CD010085-sec-0084"> <h4 class="title">N‐3 LCPUFA supplementation versus placebo or no supplementation</h4> <section id="CD010085-sec-0085"> <h5 class="title">Primary outcomes ‐ any allergy</h5> <p>See: <a href="#CD010085-tbl-0001">Table 1</a>; <a href="#CD010085-tbl-0002">Table 2</a>. </p> <div class="table" id="CD010085-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on IgE‐mediated allergies using pooled analysis RR (M‐H, Fixed/Random, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Allergy</b> (IgE mediated)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Effect Estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Food allergy</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.13 [0.02 to 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58 [0.18 to 1.88] <sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43 [0.63 to 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Eczema</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.13 to 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.61 [0.39 to 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.57 to 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Allergic rhinitis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 [0.07 to 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 [0.44 to 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Asthma</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>824</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.21 to 3.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10 [0.34 to 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergies</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.66 [0.44 to 0.98]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.61 to 1.20]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE = Not estimable , <sup>R=</sup> Random‐effects estimate </p> </div> </div> <div class="table" id="CD010085-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on all allergies using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Allergy</b> </i> (IgE mediated or not) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Effect Estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Food allergy</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.13 [0.02, 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 [0.40 to 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43 [0.63 to 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Eczema</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 [0.22 to 2.62]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 [0.69 to 1.33]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.68 to 1.13]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Allergic rhinitis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 [0.25 to 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 [0.81 to 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Asthma</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26 [0.54 to 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>955</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 [0.73 to 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 [0.78 to 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergies</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 [0.71 to 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 [0.84 to 1.09]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE= Not estimable , <sup>R=</sup> Random‐effects estimate </p> </div> </div> <p>We considered any allergy that included children with one or more allergy types including food allergy, atopic dermatitis (eczema), asthma/wheeze, allergic rhinitis (hay fever) as primary outcomes of the review. Allergic disease was considered in two ways. Firstly, the effect of n‐3 LCPUFA supplementation on IgE‐mediated allergic disease, then the effect of supplementation on all allergic disease (+/‐ IgE sensitivity) was analysed, for each of the allergic diseases under study. The effect of supplementation was analysed at various points in the child's life – short term (up to 12 months of age), medium term (12 to 36 months), and long term (36 months and beyond). We were unable to report cumulative incidences due to variation in reporting between studies. </p> <section id="CD010085-sec-0086"> <h6 class="title">Any allergies (Analysis 1.1; Analysis 1.2)</h6> <p>N‐3 LCPUFA supplementation showed a clear reduction in IgE‐mediated allergies in 12 to 36 months of age children when compared with the control group (<a href="./references#CD010085-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 823 children, risk ratio (RR) 0.66, 95% confidence interval (CI) 0.44 to 0.98). No clear differences were found in IgE‐mediated allergies between treatments in 36 months of age or older children (<a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 0.86, 95% CI 0.0.61 to 1.20). No included trials reported on combined IgE‐mediated allergies in infants under 12 months of age. </p> <p>When all allergies (+/‐ IgE sensitivity) were considered, n‐3 LCPUFA supplementation did not show clear differences in allergies in children at 12 to 36 months (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, RR 0.89, 95% CI 0.71 to 1.11, 823 children) or 36 months and beyond (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>, RR 0.96, 95% CI 0.84 to 1.09, 1765 children) (<a href="./references#CD010085-fig-0005" title="">Analysis 1.2</a>). No included trials reported on combined +/‐ IgE‐mediated allergies in infants under 12 months of age. </p> </section> </section> <section id="CD010085-sec-0087"> <h5 class="title">Secondary outcomes</h5> <p>See: <a href="#CD010085-tbl-0001">Table 1</a>; <a href="#CD010085-tbl-0002">Table 2</a>. </p> <p>As secondary outcomes, we considered specific forms of allergy including food allergy, atopic dermatitis (eczema), asthma/wheeze and allergic rhinitis (hay fever) (IgE‐mediated and +/‐ IgE sensitivity). </p> <section id="CD010085-sec-0088"> <h6 class="title">Food allergy (Analysis 2.1; Analysis 2.2)</h6> <p>N‐3 LCPUFA supplementation reduced the incidence of IgE‐mediated food allergies in children up to 12 months of age (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, 117 infants, RR 0.13, 95% 0.02 to 0.95; <a href="./references#CD010085-fig-0006" title="">Analysis 2.1</a>), but there were no clear differences found between the intervention and control groups at any other age (12 to 36 months <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 825 children, average RR 0.58, 95% CI 0.18 to 1.88; &gt; 36 months of age <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 1.43, 95% CI 0.63 to 3.26). A random‐effects analysis was used as substantial heterogeneity was noted at the 12‐ to 36‐month time point (Tau² = 0.39; P = 0.15; I² = 51%) (<a href="./references#CD010085-fig-0006" title="">Analysis 2.1</a>). The heterogeneity may be due to the duration of the intervention, the dose used and the difference in assessment ages. </p> <p>When food allergies +/‐ IgE sensitivity were considered (<a href="./references#CD010085-fig-0007" title="">Analysis 2.2</a>), results showed few differences from those for IgE‐mediated allergies (<a href="./references#CD010085-fig-0006" title="">Analysis 2.1</a>) with no differences in the direction of findings from those for IgE‐mediated allergies (up to 12 months of age, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, 117 infants, RR 0.13, 95% CI 0.02 to 0.95; between 12 to 36 months, <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 973 children, RR 0.72, 95% CI 0.40 to 1.30; &gt; 36 months of age <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 1.43, 95% CI 0.63 to 3.26). </p> </section> <section id="CD010085-sec-0089"> <h6 class="title">Eczema (Analysis 2.3; Analysis 2.4)</h6> <p>N‐3 LCPUFA supplementation reduced the incidence of IgE‐mediated eczema in children at 12 to 36 months of age (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; 823 children, RR 0.61, 95% CI 0.39 to 0.95, <a href="./references#CD010085-fig-0008" title="">Analysis 2.3</a>). There were no clear differences between groups at the other time points (&lt; 12 months <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; 117 children, RR 0.38, 95% CI 0.13 to 1.11 or &gt; 36 months of age <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 0.84, 95% CI 0.57 to 1.23) </p> <p>When eczema outcomes +/‐ IgE sensitivity were considered (<a href="./references#CD010085-fig-0009" title="">Analysis 2.4</a>), results showed few differences from those for IgE‐mediated eczema (<a href="./references#CD010085-fig-0008" title="">Analysis 2.3</a>), however the direction of effect was reversed for the 12‐ to 36‐month age group (up to 12 months of age (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>, 203 infants, average RR 0.76, 95% CI 0.22 to 2.62; between 12 to 36 months, <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 973 children, average RR 0.96, 95% CI 0.69 to 1.33; &gt; 36 months of age, <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 1237 children, average RR 0.88, 95% CI 0.68 to 1.13). A random‐effects analysis was used all time points as substantial heterogeneity was noted at the 12‐month time point (Tau² = 0.57; P = 0.06; I² = 71%) (<a href="./references#CD010085-fig-0009" title="">Analysis 2.4</a>). </p> </section> <section id="CD010085-sec-0090"> <h6 class="title">Allergic rhinitis (Analysis 2.5; Analysis 2.6)</h6> <p>No clear difference was seen between n‐3 LCPUFA and control groups in either IgE‐mediated allergic rhinitis (<a href="./references#CD010085-fig-0010" title="">Analysis 2.5</a>: 12 to 36 months, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 825 children, RR 0.47, 95% CI 0.07 to 3.06; &gt; 36 months of age, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 0.83, 95% CI 0.44 to 1.54 or allergic rhinitis +/‐ IgE sensitivity (<a href="./references#CD010085-fig-0011" title="">Analysis 2.6</a>:12 to 36 months, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 805 children, RR 0.53, 95% CI 0.25 to 1.12; &gt; 36 months of age, <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 1169 children, RR 1.03, 95% CI 0.81 to 1.30) across any age group. No included trials reported allergic rhinitis outcomes in infants under 12 months of age. </p> </section> <section id="CD010085-sec-0091"> <h6 class="title">Asthma (Analysis 2.7; Analysis 2.8)</h6> <p>No clear differences were found between n‐3 LCPUFA and control groups in children with either IgE‐mediated asthma (<a href="./references#CD010085-fig-0012" title="">Analysis 2.7</a>; 12 to 36 months, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 824 children, RR 0.86, 95% CI 0.21 to 3.49; &gt; 36 months of age, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 706 children, RR 1.10, 95% CI 0.34 to 3.58), or asthma +/‐ IgE sensitivity (<a href="./references#CD010085-fig-0013" title="">Analysis 2.8</a>; &lt; 12 months, <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>, 83 infants, RR 1.26, 95% CI 0.54 to 2.94; 12 to 36 months, <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>, <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>, <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 955 children, RR 0.93, 95% CI 0.73 to 1.18; &gt; 36 months of age, <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>, <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>, 1697 children, RR 0.94, 95% CI 0.78 to 1.13) across any age group. No included trials reported IgE‐mediated asthma outcomes in infants under 12 months of age. </p> </section> <section id="CD010085-sec-0092"> <h6 class="title">Maternal safety (Analysis 3.1)</h6> <p>There was no clear difference in postpartum haemorrhage (defined as &gt; 500 mL of blood loss post delivery) in women supplemented with n‐3 LCPUFA compared with those in the control group (<a href="./references#CD010085-fig-0014" title="">Analysis 3.1</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>, n = 2932, average RR 0.73, 95% CI 0.49 to 1.10). Given the substantial heterogeneity between trials, a random‐effects model was used (Tau² = 0.05, P = 0.11; I² = 60%; <a href="./references#CD010085-fig-0014" title="">Analysis 3.1</a>). Postpartum infection was not reported in any of the included trials. </p> </section> <section id="CD010085-sec-0093"> <h6 class="title">Infant safety (Analysis 3.2)</h6> <p>Infant safety was assessed using early childhood infections. Four trials reported this outcome (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>, 2280 infants) with no clear difference between the n‐3 LCPUFA and control group (RR 0.99; 95% CI 0.87 to 1.12). <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a> reported fever in 834 infants and found no differences between groups (RR 0.99; 95% CI 0.74 to 1.31; <a href="./references#CD010085-fig-0015" title="">Analysis 3.2</a>). </p> </section> <section id="CD010085-sec-0094"> <h6 class="title">Sensitisation to allergens (Analysis 4.1 to Analysis 4.9)</h6> <p>See: <a href="#CD010085-tbl-0003">Table 3</a>. </p> <div class="table" id="CD010085-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on skin prick results for allergens using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Skin prick results</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Fixed Effect estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Egg</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 [0.19 to 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>893</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>46</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>455</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>82</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>438</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.55 [0.39 to 0.77]</b> ٭٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 [0.30 to 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Cow’s milk</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 [0.24 to 2.29]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>897</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 [0.20 to 2.34]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Peanut</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 [0.34 to 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 [0.30 to 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Wheat</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.74 [0.16 to 89.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40 [0.29 to 6.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 [0.56 to 13.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Fish</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.36 [0.33 to 122.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.84 [0.17 to 20.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Inhalant allergens (pollens)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 [0.08 to 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 [0.44 to 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>House dust mite</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt;12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76 [0.18 to 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.48 to 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Cat</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.05 to 12.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.39 to 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.91 [0.98 to 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergen</i> </p> <p><i>(one or more allergen)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59 [0.32 to 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>892</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>68</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>455</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>93</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>437</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.70 [0.53 to 0.94]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 [0.74 to 1.22]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE = Not estimable</p> </div> </div> <p>Sensitisation is the strongest predictor of IgE‐mediated allergy and was defined by a positive skin prick test to an allergen (<a href="./references#CD010085-bbs2-0041" title="deJongAB , DikkescheiLD , BrandPL . Sensitization patterns to food and inhalant allergens in childhood: a comparison of non‐sensitized, monosensitized, and polysensitized children. Pediatric Allergy Immunology2011;22(2):166‐71. ">de Jong 2011</a>). <b>Sensitisation to egg</b> (<a href="./references#CD010085-fig-0016" title="">Analysis 4.1</a>) was reduced in the n‐3 LCPUFA group compared with the control in 12‐ to 36 month‐old children (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 893 children, RR 0.55; 95% CI 0.39 to 0.77). No clear differences between groups were seen in egg sensitisation in children up to 12 months of age (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) or in children 36 months or older (<a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). </p> <p><b>Sensitisation to cows' milk</b> was not different between the treatment groups at any age of assessment (<a href="./references#CD010085-fig-0017" title="">Analysis 4.2</a>), although no trials contained data for children aged 36 months or older. Given the substantial heterogeneity at 12 to 36 months, a random‐effects model was used (Tau² = 0.48; P = 0.19; I² = 40%). </p> <p>There were no clear differences between groups in <b>peanut sensitisation</b> at any time point (<a href="./references#CD010085-fig-0018" title="">Analysis 4.3</a>; no trials in infants under 12 months of age), </p> <p>The effect of n‐3 LCPUFA supplementation on <b>wheat sensitisation</b> was not different from the control group at any age (<a href="./references#CD010085-fig-0019" title="">Analysis 4.4</a>) and similar results were seen with <b>sensitisation to fish</b> (<a href="./references#CD010085-fig-0020" title="">Analysis 4.5</a>; no trials up to 12 months of age), <b>inhalant allergens (pollens)</b> (<a href="./references#CD010085-fig-0021" title="">Analysis 4.6</a>; no trials up to 12 months of age), <b>dust mites</b> (<a href="./references#CD010085-fig-0022" title="">Analysis 4.7</a>; no trials up to 12 months of age) and <b>cats</b> (<a href="./references#CD010085-fig-0023" title="">Analysis 4.8</a>). </p> <p>When <b>all allergens</b> were considered (<a href="./references#CD010085-fig-0024" title="">Analysis 4.9</a>), no clear differences were found between treatments for infants up to 12 months and beyond 36 months. However, n‐3 LCPUFA showed a clear reduction in sensitisation in 12 to 36 months of age children (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>, 892 children, RR 0.70; 95% CI 0.53 to 0.94). </p> </section> <section id="CD010085-sec-0095"> <h6 class="title">Parent's report of allergies from non‐validated questionnaires (Analysis 5.1 to Analysis 5.5) </h6> <p>Three trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), included parents' reports of allergy collected using non‐validated questionnaires. No clear differences were found between n‐3 LCPUFA supplementation and control at any age in the incidence of parental reports of food allergies (<a href="./references#CD010085-fig-0025" title="">Analysis 5.1</a>), eczema (<a href="./references#CD010085-fig-0026" title="">Analysis 5.2</a>), allergic rhinitis (<a href="./references#CD010085-fig-0027" title="">Analysis 5.3</a>), asthma/wheeze (<a href="./references#CD010085-fig-0028" title="">Analysis 5.4</a>), or any allergies (<a href="./references#CD010085-fig-0029" title="">Analysis 5.5</a>). </p> </section> </section> <section id="CD010085-sec-0096"> <h5 class="title">Subgroup analysis</h5> <p>Data were reported at last time point only in the subgroup analysis comparisons.</p> <section id="CD010085-sec-0097"> <h6 class="title">Timing of supplementation (Analysis 6.1 to Analysis 6.2)</h6> <p>Five trials included in the review confined supplementation with n‐3 LCPUFA to the prenatal period only (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a> collected allergy outcome data using a non‐validated questionnaire, therefore these data did not meet the inclusion criteria for the primary outcome. Two of the included trials supplemented women with n‐3 LCPUFA in the postnatal period only (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>), and only one trial (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>) supplemented women with n‐3 LCPUFA through both prenatal and postnatal periods. </p> <p>There were no significant subgroup differences for any of the outcomes (<a href="./references#CD010085-fig-0030" title="">Analysis 6.1</a>; <a href="./references#CD010085-fig-0031" title="">Analysis 6.2</a>). </p> </section> <section id="CD010085-sec-0098"> <h6 class="title">Allergy risk of the offspring (Analysis 5.1 to Analysis 5.5)</h6> <p>Four trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) provided n‐3 LCPUFA supplements to women whose fetuses were at high risk of allergy development with two reporting only IgE‐mediated allergies (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). Three trials studied the effect of n‐3 LCPUFA supplementation on allergy in women with fetuses or women with infants who were not selected on the basis of allergy risk (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>). There were no significant subgroup differences for any outcome (<a href="./references#CD010085-fig-0032" title="">Analysis 7.1</a>). </p> </section> <section id="CD010085-sec-0099"> <h6 class="title">Infant maturity</h6> <p>Subgroup analyses based on infant maturity were not able to be conducted. Although data from preterm children were available for <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>, it was not possible to separate out children according to their gestational age in the remaining included trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). <a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a> excluded preterm infants after randomisation. </p> </section> </section> <section id="CD010085-sec-0100"> <h5 class="title">Sensitivity analysis</h5> <p>Sensitivity analyses were conducted for the primary outcome removing trials with high or unclear risk of selection, performance or attrition bias; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a> and <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> were the only trials with low risk of bias across these parameters. Removing trials with high or unclear risk of bias changed the direction for IgE‐mediated any allergy at 12 to 36 months time point, but not beyond the 36 months time point, or for medically diagnosed IgE mediated and/or parental report any allergy outcome at any time points (<a href="./references#CD010085-fig-0033" title="">Analysis 8.1</a>; <a href="./references#CD010085-fig-0034" title="">Analysis 8.2</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010085-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010085-sec-0101">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010085-sec-0144">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010085-sec-0101"></div> <section id="CD010085-sec-0102"> <h3 class="title" id="CD010085-sec-0102">Summary of main results</h3> <p>Eight trials involving 3366 women with 3175 children were included in this review. Supplementation occurred during pregnancy, lactation or both pregnancy and lactation. </p> <p>Overall, the available evidence shows that maternal n‐3 LCPUFA (long chain polyunsaturated fatty acid) supplementation showed little benefit in the reduction of childhood allergic disease. There was no clear overall effect of maternal n‐3 LCPUFA supplementation on the incidence of medically diagnosed or parental reports of allergy (+/‐ IgE sensitisation) including food allergy, eczema, allergic rhinitis, asthma/wheeze or any allergy. No reduction was observed with maternal n‐3 LCPUFA supplementation on IgE‐mediated allergic rhinitis or IgE‐mediated asthma. </p> <p>However, there were reductions in some outcomes such as IgE‐mediated food allergy up to 12 months of age, IgE‐mediated eczema between one and three years of age and the risk of developing any IgE‐mediated allergic disease between one and three years of age. However, this needs to be interpreted with caution as IgE‐mediated allergies were reported in only two trials, which only focused on high‐risk populations of allergy. </p> <p>There was also a reduction in the incidence of sensitisation to egg and any allergen in children in the n‐3 LCPUFA group. </p> </section> <section id="CD010085-sec-0103"> <h3 class="title" id="CD010085-sec-0103">Overall completeness and applicability of evidence</h3> <p>The majority of the evidence came from children of women supplemented with n‐3 LCPUFA during pregnancy and/or lactation and from women with a fetus at high risk of allergy (who were supplemented during pregnancy). Most of the trials included in this review were conducted in high‐income industrialised countries and the findings are therefore applicable to the most affluent societies where the burden of allergy is known to be high. </p> <p>IgE‐mediated allergies, where both the signs and symptoms of the allergic disease and a positive skin prick test (SPT) and/or radioallergosorbent test (RAST) were present, were reported in two trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a> and all trials except three (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>), used medical diagnosis of allergy for the analyses (with IgE status not tested or unknown). </p> <p>Most allergic responses are mediated by IgE antibodies, specific to the trigger allergen (<a href="./references#CD010085-bbs2-0052" title="JohanssonSGO , O’B HourihaneJ , BousquetJ , Bruijnzeel‐KoomenC , DreborgS , HaahtelaT , et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy2001;56:813‐24. ">Johansson 2001</a>; <a href="./references#CD010085-bbs2-0081" title="SichererSH , WoodRA . Allergy testing in childhood: using allergen‐specific IgE tests. Pediatrics2012;129(1):193‐7. ">Sicherer 2012</a>). However, although the presence of IgE antibodies indicates a sensitised state, the most reliable diagnosis of allergic disease should take into account clinical history as well (<a href="./references#CD010085-bbs2-0081" title="SichererSH , WoodRA . Allergy testing in childhood: using allergen‐specific IgE tests. Pediatrics2012;129(1):193‐7. ">Sicherer 2012</a>). Thus, diagnoses involving laboratory tests (RAST), SPT and assessment of clinical symptoms are more reliable than clinical presentation or parental reports (using validated questionnaires), or laboratory reports alone. </p> <p>As asthma is difficult to diagnose in young children, authors often report 'wheeze' (<a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>); we therefore included reports of wheeze in asthma outcomes. </p> <p>The selection of women differed with respect to fish intake, with three trials targeting women with a low fish intake (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>), while fish intake was not related to inclusion criteria in other trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). One of the reasons for some of the mixed results in this review may be due to the mothers baseline intake of n‐3 LCPUFA not being considered in some studies. </p> <p>In the two trials where there was not an assigned control and women continued their 'usual diet' (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>), the women in these groups may have had a high intake of dietary n‐3 LCPUFA as the benefits of dietary n‐3 LCPUFA in pregnancy was promoted in the countries in which these two trials were conducted. </p> <p>In relation to diet and supplementation, some studies excluded women who were known to be allergic to fish (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>), as a safety precaution in case they may have reacted to fish oil capsules. Consequently, not many studies looked at fish allergy and hence data in this area may be limited (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>). </p> <p>The evidence is incomplete for subgroup comparisons on the timing of supplementation, allergy risk of infants and maturity of infants. The trial in which n‐3 LCPUFA supplementation started during pregnancy and continued through to lactation was limited by small sample size and high risk of attrition bias (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>). </p> </section> <section id="CD010085-sec-0104"> <h3 class="title" id="CD010085-sec-0104">Quality of the evidence</h3> <p>The majority of the comparisons in this review were based on data from two trials (<a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>). The quality of the evidence for each of the comparisons greatly depends on the quality of these two trials. However, other primary outcome data regardless of IgE mediation were based on all included trials except <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>. The risk of bias varied across the eight included trials with only two trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) with a low risk of selection, performance and attrition bias. </p> <p>Women's adherence to the supplementation may also impact on the outcomes. Blood analysis was used to check adherence to the supplementation in most trials (<a href="./references#CD010085-bbs2-0001" title="BardenAE , DunstanJA , BeilinLJ , PrescottSL , MoriTA . n ‐ 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science2006;111(4):289‐94. BardenAE , MoriTA , DunstanJA , TaylorAL , ThorntonCA , CroftKD , et al. Fish oil supplementation in pregnancy lowers f2‐isoprostanes in neonates at high risk of atopy. Free Radical Research2004;38(3):233‐9. DenburgJA , HatfieldHM , CyrMM , HayesL , HoltPG , SehmiR , et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research2005;57(2):276‐81. DunstanJA , MitoulasLR , DixonG , DohertyDA , HartmannPE , SimmerK , et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research2007;62(6):689‐94. DunstanJA , MoriTA , BardenA , BeilinLJ , HoltPG , CalderPC , et al. Effects of n‐3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition2004;58:429‐37. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Fish oil supplementation in pregnancy modifies neonatal allergen‐specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology2003;112(6):1178‐84. DunstanJA , MoriTA , BardenA , BeilinLJ , TaylorAL , HoltPG , et al. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy2003;33(4):442‐8. DunstanJA , RoperJ , MitoulasL , HartmannPE , SimmerK , PrescottSL . The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy2004;34(8):1237‐42. DunstanJA , SimmerK , DixonG , PrescottSL . Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition2008;93(1):F45‐F50. HatfieldHM , DunstanJA , HayesL , SehmiR , HoltPM , DenbergJA , et al. Dietary N‐3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL‐5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology2003;111(2 Suppl).):S320. MattesE , McCarthyS , GongG , vanEekelenJA , DunstanJ , FosterJ , et al. Maternal mood scores in mid‐pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity2009;23(3):380‐8. PrescottSL , BardenAE , MoriTA , DunstanJA . Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord‐blood‐derived neutrophils. Clinical Science2007;113(10):409‐16. ">Dunstan 2003</a>; <a href="./references#CD010085-bbs2-0002" title="FuruhjelmC , JenmalmMC , Falth‐MagnussonK , DuchInK . Th1 and Th2 chemokines, vaccine‐induced immunity, and allergic disease in infants after maternal ω‐3 fatty acid supplementation during pregnancy and lactation. Pediatric Research2011;69(3):259‐64. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of maternal n‐3 fatty acid supplementation during pregnancy and lactation. Allergy2008;63(Suppl 88):53. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. A randomised placebo controlled study of omega‐3‐fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy2007;62(Suppl 83):46. FuruhjelmC , WarstedtK , FagerasM , Falth‐MagnussonK , LarssonJ , FredrikssonM , et al. Allergic disease in infants up to 2 years of age in relation to plasma omega‐3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology2011;22(5):505‐14. FuruhjelmC , WarstedtK , LarssonJ , FredrikssonM , BottcherMF , Falth‐MagnussonK , et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica2009;98(9):1461‐7. WarstedtK , FuruhjelmC , DuchenK , Falth‐MagnussonK , FagerasM . The effects of omega‐3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research2009;66(2):212‐7. ">Furuhjelm 2009</a>; <a href="./references#CD010085-bbs2-0003" title="AsserhojM , NehammerS , MatthiessenJ , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation may adversely affect long‐term blood pressure, energy intake, and physical activity of 7‐year‐old boys. Journal of Nutrition2009;139(2):298‐304. CheathamCL , NerhammerAS , AsserhojM , MichaelsenKF , LauritzenL . Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids2011;46(7):637‐45. JorgensenMH , MichaelsenKF , LauritzenL . Long chain polyunsaturated fatty acids and liver biochemistry in breast‐fed infants. Journal of Pediatric Gastroenterology and Nutrition2005;40(5):631‐2. LarnkjaerA , ChristensenJH , MichaelsenKF , LauritzenL . Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5‐y‐old children. Journal of Nutrition2006;136(6):1539‐44. LauritzenL , HoppeC , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research2005;58(2):235‐42. LauritzenL , JorgensenMH , MikkelsenTB , SkovgaardM , StraarupEM , OlsenSF , et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n‐3 fatty acid content of infant erythrocytes. Lipids2004;34(3):195‐206. LauritzenL , JorgensenMH , OlsenSF , StraarupEM , MichaelsenKF . Maternal fish oil supplementation in lactation: effect on developmental outcome in breast‐fed infants. Reproduction, Nutrition, Development2005;45(5):535‐47. LauritzenL , KjaerTM , FruekildeMB , MichaelsenKF , FrokiaerH . Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2‐year‐old children. Lipids2005;40(7):669‐76. UlbakJ , LauritzenL , HansenHS , MichaelsenKF . Diet and blood pressure in 2.5‐y‐old Danish children. American Journal of Clinical Nutrition2004;79(6):1095‐102. ">Lauritzen 2005</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0007" title="BorisJ , JensenB , SalvigJD , SecherNJ , OlsenSF . A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n‐3 fatty acid content in human breast milk. Lipids2004;39(12):1191‐6. OlsenSF , OsterdalML , SalvigJD , MortensenLM , RytterD , SecherNJ , et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry‐based follow‐up from a randomized controlled trial. American Journal of Clinical Nutrition2008;88(1):167‐75. OlsenSF , OsterdalML , SalvigJD , WeberT , TaborA , SecherNJ . Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition2007;61(8):976‐85. OlsenSF , SecherNJ . Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. OlsenSF , SecherNJ , SorensenJD , GrantA . Gestational age and fish oil supplementation in third trimester: a population‐based randomized controlled trial. International Journal of Gynecology and Obstetrics1991;36 Suppl:31. OlsenSF , SorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Randomised controlled trial of effect of fish‐oil supplementation on pregnancy duration. Lancet1992;339:1003‐7. OlsenSF , SøorensenJD , SecherNJ , HedegaardM , HenriksenTB , HansenHS , et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger1994;156(9):1302‐7. RytterD , BechBH , ChristensenJH , SchmidtEB , HenriksenTB , OlsenSF . Intake of fish oil during pregnancy and adiposity in 19‐y‐old offspring: Follow‐up on a randomized controlled trial. American Journal of Clinical Nutrition2011;94(3):701‐8. RytterD , ChristensenJH , BechBH , SchmidtEB , HenriksenTB , OlsenSF . The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19‐year‐old offspring. British Journal of Nutrition2012;108(8):1475‐83. RytterD , SchmidtEB , BechBH , ChristensenJH , HenriksenTB , OlsenSF . Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids2011;46(12):1091‐9. SalvigJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1996;103:529‐33. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology1993;168:915‐22. SorensenJD , OlsenSF , PedersenAK , BorisJ , SecherNJ , FitzGeraldGA . Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics1993;43:229. SorensenJD , OlsenSF , SecherNJ . Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement1995;73:110. SorensenJD , OlsenSF , SecherNJ , JespersenJ . Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis1994;8:54‐60. VanHouwelingenAC , SorensenJD , HornstraG , SimonisMMG , BorisJ , OlsenSF , et al. Essential fatty acid status in neonates after fish‐oil supplementation during late pregnancy. British Journal of Nutrition1995;74:723‐31. ">Olsen 1992</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>), and all reported a significant n‐3 LCPUFA increase in the intervention group. The use of fish, rather than fish oil as a supplement also needs consideration as it may contribute to the energy and protein content in the maternal diet and influence outcomes in a different way. In this review we included one trial (<a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>) which supplemented with fish, however this trial had been designed to overcome any additional effect of the diet by using it as a replacement for white fish, chicken and some red meat; thus minimising any additional energy and protein contributions (personal communication <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>). </p> </section> <section id="CD010085-sec-0105"> <h3 class="title" id="CD010085-sec-0105">Potential biases in the review process</h3> <p>Our search strategy was comprehensive and was not limited by language or publication status. We searched the major international and local bibliographic databases, handsearched major journals and the proceedings of major conferences in the field and set weekly current awareness alerts for a further 44 journals as well as monthly BioMed Central email alerts. We used a clear inclusion criteria and thorough quality assessment methodology to appraise each trial. Two review authors (AWG, CTC) independently screened and appraised the trials, and used pre‐designed data extraction forms to extract data. Therefore, biases in the review process are unlikely. Review authors MM and CTC were investigators on two trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>) included in the review. These trials were independently assessed for inclusion, risk of bias and data extracted by AWG and an independent researcher Karen Best (KB). </p> </section> <section id="CD010085-sec-0106"> <h3 class="title" id="CD010085-sec-0106">Agreements and disagreements with other studies or reviews</h3> <p>Two systematic reviews (<a href="./references#CD010085-bbs2-0055" title="KlemensCM , BermanDR , MozurkewichEL . The effect of perinatal omega‐3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG: an international journal of obstetrics and gynaecology2011;118(8):916‐25. ">Klemens 2011</a>; <a href="./references#CD010085-bbs2-0057" title="KremmydaLS , VlachavaM , NoakesPS , DiaperND , MilesEA , CalderPC . Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long‐chain omega‐3 fatty acids: a systematic review. Clinical Review Allergy Immunology2011; Vol. 41, issue 1:36‐66. ">Kremmyda 2011</a>), have been recently published on this topic. <a href="./references#CD010085-bbs2-0057" title="KremmydaLS , VlachavaM , NoakesPS , DiaperND , MilesEA , CalderPC . Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long‐chain omega‐3 fatty acids: a systematic review. Clinical Review Allergy Immunology2011; Vol. 41, issue 1:36‐66. ">Kremmyda 2011</a> aimed to determine the effect of n‐3 LCPUFA supplementation during the perinatal period on allergies (irrespective of IgE status) in children, but did not conduct a meta‐analysis. <a href="./references#CD010085-bbs2-0055" title="KlemensCM , BermanDR , MozurkewichEL . The effect of perinatal omega‐3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG: an international journal of obstetrics and gynaecology2011;118(8):916‐25. ">Klemens 2011</a> conducted a meta‐analysis and reported that n‐3 LCPUFA supplementation during pregnancy reduced the incidence of childhood asthma but had no effect on atopic dermatitis. Their analysis did not include the most recent trials (<a href="./references#CD010085-bbs2-0004" title="AtwellK , CollinsCT , SullivanTR , RyanP , GibsonRA , MakridesM , et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health2013;49(1):E17‐E22. CollinsCT , GibsonRA , MillerJ , McPheeAJ , WillsonK , SmithersLG , et al. Carbohydrate intake is the main determinant of growth in infants born &lt;33 weeks' gestation when protein intake is adequate. Nutrition2008;24:451‐7. CollinsCT , MakridesM , GibsonRA , McPheeAJ , DavisPG , DoyleLW , et al. Pre and post‐term growth in pre‐term infants supplemented with higher‐dose DHA: a randomised controlled trial. British Journal of Nutrition2011;105(11):1635‐43. GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. HawkesJS , BryanDL , MakridesM , NeumannMA , GibsonRA . A randomized trial of supplementation with docosahexaenoic acid‐rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition2002;75(4):754‐60. MakridesM , GibsonRA , McPheeAJ , CollinsCT , DavisPG , DoyleLW , et al. Neurodevelopmental outcomes of preterm infants fed high‐dose docosahexaenoic acid: a randomised controlled trial. JAMA2009;301(2):175‐82. ManleyBJ , MakridesM , CollinsCT , McPheeAJ , GibsonRA , RyanP , et al. High‐dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics2011;128(1):e71‐e77. SimmondsL . Behavioural and Allergic Disease Assessment at Pre‐School Age: A Follow‐up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov. SmithersLG , CollinsCT , SimmondsLA , GibsonRA , McPheeA , MakridesM . Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow‐up study of a randomised controlled trial. American Journal of Clinical Nutrition2010;91(3):628‐34. SmithersLG , GibsonRA , MakridesM . Long‐chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews2007;8:143‐51. SmithersLG , GibsonRA , McPheeA , MakridesM . Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids2008;79(3‐5):141‐6. SmithersLG , GibsonRA , McPheeA , MakridesM . Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition2008;88(4):1049‐56. SmithersLG , MakridesM , GibsonRA . Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra‐ and inter‐individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids2010;83(1):9‐13. ">Makrides 2009</a>; <a href="./references#CD010085-bbs2-0005" title="GunaratneAW . Effects of n‐3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis‐submitted]. University of Adelaide, 2014 July. MakridesM . A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005]2005. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ . Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health2011;47(Suppl 1):89. MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. MakridesM , GouldJF , GawlikNR , YellandLN , SmithersLG , AndersonPJ , et al. Four‐year follow‐up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA2014;311(17):1802‐4. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ2012;344(e184):1‐11. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Effect of n‐3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health2013;49 Suppl(2):56. PalmerDJ , SullivanT , GoldMS , PrescottSL , HeddleR , GibsonRA , et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy2013;68(11):1370‐6. RyanP , GriffithE , McDermottB , MakridesM , GibsonR , for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials2007;4(4):426. SmithersLG , GibsonRA , MakridesM . Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition2011;93(6):1293‐9. ZhouSJ , YellandL , McPheeAJ , QuinlivanJ , GibsonRA , MakridesM . Fish‐oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition2012;95(6):1378‐84. ">Makrides 2010</a>; <a href="./references#CD010085-bbs2-0006" title="Garcia‐RodriguezC , Helmersson‐KarlqvisJ , MesaM , MilesE , NoakesP , VlachavaM , et al. Increased intake of salmon decreases F2‐isoprostanes in pregnant women. Annals of Nutrition and Metabolism2011;58(Suppl 3):122‐3. Garcia‐RodriguezC , MesaM , OlzaJ , VlachavaM , KremmydaL , DiaperN , et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism2011;58(Suppl 3):89‐90. Garcia‐RodriguezCE , Helmersson‐KarlqvistJ , MesaMD , MilesEA , NoakesPS , VlachavaM , et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling2011;15(11):2819‐23. Garcia‐RodriguezCE , MesaMD , OlzaJ , VlachavaM , KremmydaLS , DiaperND , et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling2012;16(12):1401‐6. Garcia‐RodriguezCE , OlzaJ , AguileraCM , MesaMD , MilesEA , NoakesPS , et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition2012;142(7):1191‐6. Helmersson‐KarlqvistJ , MilesEA , VlachavaM , KremmydaLS , NoakesPS , DiaperND , et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids2012;86(1‐2):35‐8. MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , RosenlundG , et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n‐3 fatty acid intake, and marine n‐3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition2011;94(6 Suppl):1986S‐92S. NoakesPS , VlachavaM , KremmydaLS , DiaperND , MilesEA , Erlewyn‐LajeunesseM , et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition2012;95(2):395‐404. RossaryA , FargesM , LamasB , MilesEA , NoakesPS , KremmydaL , et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition2014;33(2):267‐73. RossaryA , FargesMC , VlachavaM , KremmydaLS , DiaperND , NoakesPS , et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical NutritionSupplement 2011;6(1):109. UrwinHJ , MilesEA , NoakesPS , KremmydaL , VlachavaM , DiaperND , et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition2014;111(5):733‐84. UrwinHJ , MilesEA , NoakesPS , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition2012;142(8):1603‐10. van denElsenLW , NoakesPS , van derMaarelMA , KremmydaLS , VlachavaM , DiaperND , et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition2011;94(6):1418‐25. ">Noakes 2012</a>; <a href="./references#CD010085-bbs2-0008" title="Escamilla‐NunezMC , Barraza‐VillarrealA , Hernandez‐CadenaL , Navarro‐OlivosE , SlyPD , RomieuI . Omega‐3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest2014; Vol. 146, issue 2:373‐82. HernandezE , Barraza‐VillarrealA , Escamilla‐NunezMC , Hernandez‐CadenaL , SlyPD , NeufeldLM , et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy &amp; Asthma Proceedings2013;34(5):e27‐34. Imhoff‐KunschB , SteinAD , MartorellR , Parra‐CabreraS , RomieuI , RamakrishnanU . Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics2011;128(3):e505‐12. Imhoff‐KunschB , SteinAD , VillalpandoS , MartorellR , RamakrishnanU . Docosahexaenoic acid supplementation from mid‐pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition2011;141(2):321‐6. LeeHS , Barraza‐VillarrealA , Hernandez‐VargasH , SlyPD , BiessyC , RamakrishnanU , et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega‐3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition2013;98(2):480‐7. RamakrishnanU , DiA , SchnaasL , SteinAD , WangM , MartorellR , et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 227.6. RamakrishnanU , SteinAD , Parra‐CabreraS , WangM , Imhoff‐KunschB , Juirez‐MirquezS , et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double‐blind, placebo‐controlled trial in Mexico. Food and Nutrition Bulletin2010;31(2 Suppl):S108‐16. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology2008;167(11):S23. RomieuI , Barraza‐VillarrealA , Hernandez‐CadenaL , Escamilla‐NunezC , SlyP , NeulfeldL , et al. Supplementation with omega‐3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4‐8; Berlin, Germany. 2008:346s. RomieuI , HernandezE , Barraza‐VillarrealA , Escamilla‐NunezC , SlyP , NeufeldL , et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega‐3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology2009;123(2 Suppl 1):S193. RomieuI , LeeH , BarrazaA , BiessyC , Duarte‐SallesT , SlyP , et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal2014;28(1 Suppl 1):1120.3. SteinAD , WangM , MartorellR , NeufeldL , Flores‐AyalaR , RiveraJ , et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo‐controlled trial in Mexico. FASEB Journal2010;24(Suppl):Abstract no 277.5. SteinAD , WangM , MartorellR , NeufeldLM , Flores‐AyalaR , RiveraJA , et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition2011;141(2):316‐20. SteinAD , WangM , RiveraJA , MartorellR , RamakrishnanU . Auditory‐and visual‐evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition2012;142(8):1577‐81. ">Ramakrishnan 2010</a>). Neither of the <a href="./references#CD010085-bbs2-0055" title="KlemensCM , BermanDR , MozurkewichEL . The effect of perinatal omega‐3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG: an international journal of obstetrics and gynaecology2011;118(8):916‐25. ">Klemens 2011</a> or <a href="./references#CD010085-bbs2-0057" title="KremmydaLS , VlachavaM , NoakesPS , DiaperND , MilesEA , CalderPC . Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long‐chain omega‐3 fatty acids: a systematic review. Clinical Review Allergy Immunology2011; Vol. 41, issue 1:36‐66. ">Kremmyda 2011</a> reviews separated IgE‐mediated allergies from allergies with or without IgE mediation. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010085-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010085-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010085-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010085-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy, Outcome 1 Any allergies (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy, Outcome 1 Any allergies (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy, Outcome 2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy, Outcome 2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 1 Food allergies (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 1 Food allergies (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 2 Food allergies (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 2 Food allergies (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 3 Atopic dermatitis/Eczema (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 3 Atopic dermatitis/Eczema (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 4 Atopic dermatitis/Eczema (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 4 Atopic dermatitis/Eczema (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 5 Allergic rhinitis/Hay fever (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 5 Allergic rhinitis/Hay fever (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 6 Allergic rhinitis/Hay fever (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 6 Allergic rhinitis/Hay fever (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 7 Asthma/Wheeze (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 7 Asthma/Wheeze (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 8 Asthma/Wheeze (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy, Outcome 8 Asthma/Wheeze (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety, Outcome 1 Maternal safety." data-id="CD010085-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety, Outcome 1 Maternal safety. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety, Outcome 2 Infants safety." data-id="CD010085-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety, Outcome 2 Infants safety. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 1 Skin prick test results ‐ egg." data-id="CD010085-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 1 Skin prick test results ‐ egg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 2 Skin prick test results ‐ cows' milk." data-id="CD010085-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 2 Skin prick test results ‐ cows' milk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 3 Skin Prick Test results ‐ peanut." data-id="CD010085-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 3 Skin Prick Test results ‐ peanut. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 4 Skin prick test results ‐ wheat." data-id="CD010085-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 4 Skin prick test results ‐ wheat. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 5 Skin prick test results ‐ fish." data-id="CD010085-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 5 Skin prick test results ‐ fish. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 6 Skin prick test results ‐ inhalant allergen (pollens)." data-id="CD010085-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 6 Skin prick test results ‐ inhalant allergen (pollens). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 7 Skin prick test results ‐ house dust mite." data-id="CD010085-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 7 Skin prick test results ‐ house dust mite. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 8 Skin prick test results ‐ cat." data-id="CD010085-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 8 Skin prick test results ‐ cat. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 9 Skin prick test results ‐ any allergen." data-id="CD010085-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation, Outcome 9 Skin prick test results ‐ any allergen. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 1 Food allergies: parental reported (non‐validated questionnaires)." data-id="CD010085-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 1 Food allergies: parental reported (non‐validated questionnaires). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 2 Eczema: parental reported (non‐validated questionnaires)." data-id="CD010085-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 2 Eczema: parental reported (non‐validated questionnaires). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 3 Allergic rhinitis/Hay fever: parental reported (non‐validated questionnaires)." data-id="CD010085-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 3 Allergic rhinitis/Hay fever: parental reported (non‐validated questionnaires). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 4 Asthma/Wheeze: parental reported (non‐validated questionnaires)." data-id="CD010085-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 4 Asthma/Wheeze: parental reported (non‐validated questionnaires). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 5 Any allergies: parental reported (non‐validated questionnaires)." data-id="CD010085-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire), Outcome 5 Any allergies: parental reported (non‐validated questionnaires). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup, Outcome 1 Any allergies: last available time (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup, Outcome 1 Any allergies: last available time (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup, Outcome 2 Any allergies: last available time (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup, Outcome 2 Any allergies: last available time (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Allergy risk ‐ high risk versus unselected risk subgroup, Outcome 1 Any allergy: last available time." data-id="CD010085-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Allergy risk ‐ high risk versus unselected risk subgroup, Outcome 1 Any allergy: last available time. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis, Outcome 1 Any allergies (with sensitisation): medically diagnosed IgE mediated." data-id="CD010085-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis, Outcome 1 Any allergies (with sensitisation): medically diagnosed IgE mediated. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010085-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/urn:x-wiley:14651858:media:CD010085:CD010085-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_t/tCD010085-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis, Outcome 2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported." data-id="CD010085-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis, Outcome 2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/media/CDSR/CD010085/image_n/nCD010085-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD010085-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on IgE‐mediated allergies using pooled analysis RR (M‐H, Fixed/Random, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Allergy</b> (IgE mediated)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Effect Estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Food allergy</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.13 [0.02 to 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58 [0.18 to 1.88] <sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43 [0.63 to 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Eczema</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38 [0.13 to 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.61 [0.39 to 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.57 to 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Allergic rhinitis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47 [0.07 to 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 [0.44 to 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Asthma</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>824</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.21 to 3.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10 [0.34 to 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergies</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.66 [0.44 to 0.98]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 [0.61 to 1.20]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE = Not estimable , <sup>R=</sup> Random‐effects estimate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on IgE‐mediated allergies using pooled analysis RR (M‐H, Fixed/Random, 95% CI)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010085-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on all allergies using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Allergy</b> </i> (IgE mediated or not) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Effect Estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Food allergy</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.13 [0.02, 0.95]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 [0.40 to 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43 [0.63 to 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Eczema</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 [0.22 to 2.62]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 [0.69 to 1.33]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.68 to 1.13]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Allergic rhinitis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53 [0.25 to 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 [0.81 to 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Asthma</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26 [0.54 to 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>955</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 [0.73 to 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 [0.78 to 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergies</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 [0.71 to 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 [0.84 to 1.09]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE= Not estimable , <sup>R=</sup> Random‐effects estimate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on all allergies using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010085-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on skin prick results for allergens using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Skin prick results</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Assessed Age</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of studies</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>No of participants</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>n‐3 LCPUFA</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><i><b>Placebo</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><i><b>Fixed Effect estimate</b> </i> </p> <p><i><b>RR [95% CI]</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Events</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Total</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Egg</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 [0.19 to 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>893</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>46</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>455</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>82</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>438</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.55 [0.39 to 0.77]</b> ٭٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 [0.30 to 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Cow’s milk</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 [0.24 to 2.29]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>897</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 [0.20 to 2.34]<sup>R</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Peanut</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 [0.34 to 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 [0.30 to 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Wheat</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.74 [0.16 to 89.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40 [0.29 to 6.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 [0.56 to 13.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Fish</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.36 [0.33 to 122.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.84 [0.17 to 20.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Inhalant allergens (pollens)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44 [0.08 to 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 [0.44 to 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>House dust mite</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt;12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76 [0.18 to 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.48 to 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Cat</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.05 to 12.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 [0.39 to 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.91 [0.98 to 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><i>Any allergen</i> </p> <p><i>(one or more allergen)</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59 [0.32 to 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12‐36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>892</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>68</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>455</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>93</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>437</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.70 [0.53 to 0.94]</b> ٭ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 [0.74 to 1.22]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>*significant P &lt; 0.05, ٭٭ significant P &lt; 0.005, NE = Not estimable</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">The effects of n‐3 LCPUFA supplementation on skin prick results for allergens using pooled analysis RR (M‐H, Fixed, 95% CI)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/full#CD010085-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any allergies (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.44, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1765</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ any allergy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Food allergies (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.18, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.63, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Food allergies (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Up to 12 months  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 to 36 months  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.40, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.63, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Atopic dermatitis/Eczema (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.13, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.39, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.57, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Atopic dermatitis/Eczema (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.22, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.69, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.68, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Allergic rhinitis/Hay fever (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.07, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.44, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Allergic rhinitis/Hay fever (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.25, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.81, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Asthma/Wheeze (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>824</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.21, 3.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.34, 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Asthma/Wheeze (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.54, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 to 36 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>955</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.73, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ specific forms of allergy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal safety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Postpartum bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.49, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Infants safety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Early childhood infections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.74, 1.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ maternal and infant safety</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Skin prick test results ‐ egg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.19, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>893</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.39, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.30, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Skin prick test results ‐ cows' milk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.24, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>897</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.20, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Skin Prick Test results ‐ peanut <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.34, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.30, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Skin prick test results ‐ wheat <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.74 [0.16, 89.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.29, 6.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [0.56, 13.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Skin prick test results ‐ fish <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.36 [0.33, 122.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.17, 20.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Skin prick test results ‐ inhalant allergen (pollens) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>779</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.08, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.44, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Skin prick test results ‐ house dust mite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.18, 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.48, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Skin prick test results ‐ cat <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.05, 12.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.39, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [0.98, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Skin prick test results ‐ any allergen <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.32, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.53, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.74, 1.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ allergen sensitisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Food allergies: parental reported (non‐validated questionnaires) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Up to 12 months  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.44 [0.33, 124.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 12 to 36 months  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.36, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Eczema: parental reported (non‐validated questionnaires) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.65, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.74, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.77, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Allergic rhinitis/Hay fever: parental reported (non‐validated questionnaires) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.60 [0.22, 95.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.26, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.78, 3.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Asthma/Wheeze: parental reported (non‐validated questionnaires) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1529</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.73, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 to 36 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>745</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.72, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Any allergies: parental reported (non‐validated questionnaires) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Up to 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.65, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.74, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.64, 1.30]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ parent's reports of allergy (non‐validated questionnaire)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any allergies: last available time (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.59, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Prenatal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Prenatal and postnatal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.17, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any allergies: last available time (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Prenatal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.75, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Postnatal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>531</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Prenatal and postnatal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.44, 1.38]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Timing of supplementation ‐ prenatal versus postnatal versus pre and postnatal subgroup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Allergy risk ‐ high risk versus unselected risk subgroup</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any allergy: last available time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unselected risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1059</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.82, 1.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Allergy risk ‐ high risk versus unselected risk subgroup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010085-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any allergies (with sensitisation): medically diagnosed IgE mediated <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.44, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any allergies (+/‐ sensitisation): medically diagnosed/parental reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 12 to 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.71, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Beyond 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.86, 1.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">n‐3 LCPUFA supplementation versus placebo or no supplementation ‐ sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010085.pub2/references#CD010085-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010085.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010085-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010085-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010085-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010085-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD010085-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ru#CD010085-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010085\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010085\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010085\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010085\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010085\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010085.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010085.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010085.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010085.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010085.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727051951"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010085.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727051955"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010085.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea2a00833f401',t:'MTc0MDcyNzA1Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 